Integrative analysis of endocrine-disrupting chemical effects in the developing hypothalamus : adult behaviors and neural networks by Topper, Viktoria Yuryevna
 
 
 
 
 
 
 
 
 
Copyright 
by 
Viktoria Yuryevna Topper 
2015 
 
 
  
The Dissertation Committee for Viktoria Yuryevna Topper Certifies that this is the 
approved version of the following dissertation: 
 
 
Integrative analysis of endocrine-disrupting chemical effects in the 
developing hypothalamus: adult behaviors and neural networks 
 
 
 
 
Committee: 
 
Andrea Gore, Supervisor 
David Crews 
Adron Harris 
Hans Hofmann 
Steven Phelps 
 
Integrative analysis of endocrine-disrupting chemical effects in the 
developing hypothalamus: adult behaviors and neural networks 
 
 
by 
Viktoria Yuryevna Topper, B.S. 
 
 
 
Dissertation 
Presented to the Faculty of the Graduate School of 
The University of Texas at Austin 
in Partial Fulfillment 
of the Requirements 
for the Degree of 
 
Doctor of Philosophy 
 
 
The University of Texas at Austin 
May 2015 
Dedication 
 
For my husband, Dr. Stephen Topper
 v 
Acknowledgements 
There are many people for me to thank who have helped me in this journey to 
obtain a PhD. I will start by thanking my family for their love, support, and 
encouragement despite the distance that separates us. My parents were instrumental in 
giving me the numerous opportunities to travel and experience life at the fullest, and 
always supporting me in the graduate school endeavors. My sister has been a wonderful 
companion for shopping, late-night snacking, and clothes exchange during time away 
from lab.  
A special thank you goes to my husband, Dr. Stephen Topper, whose support and 
unwavering love made this possible. Without you I am sure I could not have made it 
through this program, certainly not with my sanity intact.  
I would also like to thank Dr. Andrea Gore for taking me on as her graduate 
student. Her delight in research and in the noble pursuit of knowledge has served as my 
inspiration these past years. Thank you for always being there for me, this dissertation 
would not have happened without your guidance, patience, and encouragement. The 
never-ending supply of sweets on your desk has always had a cheering effect on me.  
There are also many members of the Gore lab that deserve special recognition. 
Dr. Deena Walker provided the inspiration and background work on developmental 
microRNA study. I was inspired by her knowledge and work ethic in those first years we 
worked together and grateful for the animal tissue that she generously allowed me to use. 
Lindsay Thompson, our lab manager, put in many hours training me in my first year in 
the lab and subsequently organizing my behavior study, and deserves a special thank you. 
Of course, I would also like to thank my other friends and colleagues in the Gore lab. Dr. 
Weiling Yin, Michael Reilly, Alexandra Garcia, Dr. Margaret Bell, Dr. Jan Mennigen, 
 vi 
and Brette Hannigan, you made the lab a wonderful, inviting place to learn and work. A 
special thank you to my undergraduate students (Lauren Wagner, Saazina Afsah, Andrea 
Chase, Jayden Chen, Karie Otto, and Barron Preston), who have helped in many aspects 
of the experiments. 
Finally, I would like to thank the members of my dissertation committee (Dr. 
David Crews, Dr. Adron Harris, Dr. Hans Hofmann, and Dr. Steven Phelps) who have 
given valuable time, insight, and feedback that made this work possible. This work was 
funded by an NIH grant from NIEHS (RO1 ES020662) to Dr. Andrea Gore. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
Integrative analysis of endocrine-disrupting chemical effects in the 
developing hypothalamus: adult behaviors and neural networks 
 
Viktoria Yuryevna Topper, Ph.D. 
The University of Texas at Austin, 2015 
 
Supervisor:  Andrea C. Gore 
 
Endocrine-disrupting chemicals (EDCs) are environmental pollutants known to 
perturb hormone systems and interfere with normal endocrine function.  Exposure to 
EDCs during hormone-sensitive developmental periods can result in profound 
dysfunction in reproductive physiology and behavior. In this dissertation, effects of 
gestational exposure to a class of EDCs called polychlorinated biphenyls (PCBs) were 
examined in the developing hypothalamus, which is known to control reproductive 
physiology and behavior in vertebrates. The specific hypothesis was that PCBs caused 
changes in sexually dimorphic hypothalamic nuclei, resulting in perturbation of adult 
sociosexual behaviors and alteration of neural networks with changes in expression of 
microRNAs and genes during development and in adulthood.   
This research focused on two brain areas relevant to understanding the PCB 
effects on the developing hypothalamus: 1) microRNA and related target gene expression 
during postnatal development, 2) adult sociosexual behaviors and gene expression. In 
both sections, molecular changes were examined in two sexually dimorphic hypothalamic 
 viii 
nuclei, medial preoptic nucleus (MPN) and ventromedial nucleus (VMN), known for 
their role in regulation of sociosexual behavior. In the first section of the dissertation, the 
effects of PCBs were examined on the expression of microRNAs and target genes at four 
ages during postnatal [P] development (P15, P30, P45, and P90). Age and sex specific 
effects were observed in both MPN and VMN, with greater effects in the MPN. The 
second research section of the dissertation explored whether sociosexual behaviors, 
namely ultrasonic vocalizations and sociosexual preference behaviors, were altered by 
gestational PCBs. Expression of forty-eight neuroendocrine candidate genes was also 
examined in the MPN and VMN of the same animals. Several sociosexual behaviors 
were affected, including number and acoustic properties of ultrasonic vocalizations, and 
nose-touching with opposite-sex animals. Gene expression was altered in sex and region-
specific manner in the brains of behaviorally affected rats.  Taken together, these findings 
suggest that gestational PCBs have lasting effects on molecular mechanisms during 
postnatal development and in adulthood, and could result in altered sociosexual behavior. 
These results have implications for human health and disease, as early life exposures to 
EDCs have been linked to reproductive decline in humans. 
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Chapter 1:  General introduction 
 
Background on reproductive physiology  
Sex differences in reproductive physiology and behavior are critical to the 
survival of vertebrate animals. Reproduction is controlled by the hypothalamic-pituitary-
gonadal [HPG] axis, and sexual dimorphism is apparent at all levels of the system. The 
HPG axis includes finely controlled hypothalamic signals to the anterior pituitary, which 
in turn sends hormonal stimuli to the gonads, ovaries in females, or testes in males (Gore, 
2010). The hypothalamus, located at the most rostral region of the brainstem, is a key 
neural center that regulates homeostatic functions in the body, integrates internal and 
external stimuli in the environment, and orchestrates the energetically costly process of 
reproduction. The gonadotropin-releasing hormone [GnRH] neuron bodies are located in 
hypothalamic preoptic area [POA] and mediobasal hypothalamus, with their axons 
extending to the median eminence at the base of the hypothalamus (Yin et al., 2010). The 
GnRH peptide is released from the axonal neuroterminals in the median eminence into 
the portal capillary system in a pulsatile manner. The release of a neurotransmitter 
peptide directly into the bloodstream is a defining feature of neuroendocrine cells; thus 
the GnRH peptide can be also appropriately referred to as a hormone or neurohormone. 
In the bloodstream, GnRH is transported to the anterior pituitary, where it acts 
upon its receptors to cause a similarly pulsatile release of pituitary gonadotropins: 
luteinizing hormone [LH] and follicle-stimulating hormone [FSH]. These hormones are 
released into the general circulation, and exert their effects on the gonads to drive 
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steroidogenesis and gametogenesis. Gonadal steroids [estrogen, testosterone, and 
progesterone], also known as sex steroid hormones, then act upon their respective steroid 
hormone receptors that are widely and heterogeneously expressed in reproductive and 
non-reproductive target tissues, including reproductive tract, genitalia, breast, bone, fat, 
muscle, kidney, liver, and many other organ systems (Takeda et al., 1990; Kuiper et al., 
1997; Uotinen et al., 1999). Steroid hormone receptors are also abundant in the central 
nervous system and pituitary gland, which enables gonadal hormones to exert feedback 
on the hypothalamic and pituitary levels of the HPG axis (Chakraborty et al., 2003). 
In the male brain, steroid hormone feedback involves negative feedback from 
testosterone and estradiol (Gooren, 1989). In females, the ovarian hormones estradiol and 
progesterone exert mostly negative feedback on the hypothalamic and pituitary hormone 
release. However, during the mid- to late follicular stage in primates, or on the day of 
proestrus in rats with a four-to-five-day estrous cycle, estradiol stimulates the release of 
GnRH, with the subsequent surge in LH, which causes ovulation (Gore, 2010). 
Interestingly, GnRH neurons themselves do not express most of the steroid hormone 
receptors; instead, negative feedback occurs via indirect effects of hormones on 
interneurons and glial cells that are abundant in estrogen [ER], progesterone [PR], and 
androgen receptors [AR] and support the GnRH neuron function (Herbison, 2008). 
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Hormonal and sex differences in the hypothalamus 
During development, the brain is organized by gonadal steroids during the critical 
period of sexual differentiation from late embryonic to early postnatal development 
(Phoenix et al., 1959; Barraclough, 1961). The concept of this critical period was first 
suggested by Phoenix et al. in 1959 and has since been extensively studied. Briefly, in 
male mammals, the developing embryonic testes produce testosterone (Forest, 1975), 
which is released into fetal general circulation, masculinizing reproductive and non-
reproductive tissues. In the brain, this masculinization is achieved through high levels of 
the aromatase enzyme, which converts fetal testosterone to estradiol (Roselli et al., 1985). 
Estradiol binds to estrogen receptors and activates the signaling cascades responsible for 
masculinization and defeminization of the developing male brain (Nordeen et al., 1983; 
Kudwa et al., 2005). Conversely, in the developing females, the ovary produces relatively 
low amounts of sex steroid hormones, resulting in brain feminization and 
demasculinization. These organizational effects of hormones on the male and female 
developing brains are necessary for the manifestation of sexually dimorphic adult 
physiology and behavior. 
Although many parts of the nervous system are sexually dimorphic in structure 
and function, the most well-studied component is the hypothalamus. For example, the 
anteroventral periventricular nucleus [AVPV], which provides input to GnRH neurons 
and is important for the female preovulatory GnRH/LH surge, is approximately two times 
larger in volume, cell number, and density in adult females than in males (Bleier et al., 
1982; Sumida et al., 1993). Conversely, the volumes of the sexually dimorphic nucleus of 
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the preoptic area [POA] and the medial preoptic nucleus [MPN] are two to four times 
higher in male rats than in the female rats (Gorski et al., 1978; Gorski et al., 1980). These 
regions are involved in regulating masculine and feminine sexual physiology and 
behavior [POA, MPN] (Davis et al., 1996). Beyond the hypothalamus, the spinal nucleus 
of the bulbocavernosis [SNB] and bed nucleus of stria terminalis [BNST] are both larger 
in males than in females (Nordeen et al., 1985; Chung et al., 2000). In males, the SNB is 
involved in maintaining the penile erection, while females lack the bulbocavernousus 
muscle that the SNB innervates, thus this region is virtually absent and plays minimal 
physiological role in females (Breedlove, 1986; Johansen et al., 2004). The BNST is 
involved in masculine and feminine reproductive physiology and affective behavioral 
pathways (Simerly, 2002). Thus, many regions of the rodent nervous system are sexually 
dimorphic in size and structure, due to the effects of sex hormones on the developing 
brain.  
While morphological differences in brain regions are part of sexual differentiation 
of the brain, more importantly, the neurochemistry and expression of neuropeptides, 
neurotransmitters, and receptors exhibit a number of sex differences. This dissertation 
will discuss a subset of such targets: steroid hormone receptors [Ar, androgen receptor; 
Esr1, estrogen receptor α; Esr2, estrogen receptor β], kisspeptin [Kiss1], and social 
behavior genes [Oxt, oxytocin; Oxtr, oxytocin receptor; Avp, vasopressin; Avpr1a, 
vasopressin receptor 1a], specifically in rats and mice.  
A variety of immunohistochemical studies have shown that there is sexual 
dimorphism in the distribution pattern of neuronal cell bodies and fibers containing Ar, 
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Esr1, Esr2 and Kiss1 in the hypothalamus (Herbison et al., 1993a; Herbison et al., 1993b; 
Dickerson et al., 2011a). Furthermore, in situ hybridization histochemical studies have 
revealed sex differences in mRNA expression of the same signaling receptors in the 
hypothalamus (Simerly et al., 1990; Chakraborty et al., 2010). In adult females, Esr1, 
Esr2, and Kiss1 are more abundant in the medial basal hypothalamus and preoptic area 
than in adult males; whereas Ar expression is higher in adult male hypothalamus than in 
adult females (Lauber et al., 1991; Herbison et al., 1993a; Imamura, 2011; Walker et al., 
2012). Additionally, Kiss1 gene and kisspeptin protein expression levels in the 
anteroventral periventricular nucleus [AVPV] of the hypothalamus are sexually 
differentiated, with adult females displaying higher levels than males (Kauffman, 2009).  
The neuropeptides and their receptors involved in social and sociosexual 
behaviors are, not surprisingly, sexually dimorphic in the brain. Within and beyond 
hypothalamus, Oxtr, Avp, and Avpr1a gene expression is higher in males than in females 
in ventromedial hypothalamus [Oxtr], bed nucleus of stria terminalis [Avp], and medial 
amygdala [Oxtr, Avp, Avpr1a] (de Vries et al., 1984; Bale et al., 1995; Ferguson et al., 
2001). Oxytocin gene expression was examined but found not to be sexually dimorphic in 
paraventricular nucleus of the hypothalamus, among other regions (Nomura et al., 2002). 
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Sexually dimorphic behaviors and hormonal influences 
Sex differences in brain morphology and steroid hormone levels are necessary for 
the manifestation of sex-appropriate behaviors, including copulatory and social 
behaviors. In male rodents, commonly analyzed copulatory behaviors include mounting 
females, penile intromissions, and ejaculations. Measurements of feminine copulatory 
behavior include proceptive [hops, darts, ear wiggling] and receptive [lordosis] 
behaviors. The brain regions controlling these behaviors in both sexes are almost entirely 
overlapping and include medial amygdala, BNST, POA, and ventromedial nucleus 
[VMN], as well as other midbrain, hypothalamic, and forebrain regions (Malsbury et al., 
1977; Mathews et al., 1977; Clark et al., 1981; Kato et al., 2000; Hull et al., 2006). It is 
possible that within these regions, the differences in steroid hormone receptors, 
neurotransmitters, neuron numbers, and phenotypes result in sex differences in behavior. 
Additionally, sex-dependent levels of estradiol, progesterone, and testosterone may exert 
sex-typical effects on the HPG axis, leading to the manifestation of male-like and female-
like behaviors (Crews, 2012). 
 
Male copulatory behaviors 
The importance of testosterone in regulating male-typical sexual behavior is 
shown by castration studies. Castration caused a decrease in serum testosterone levels 
and a corresponding decrease of sexual behavior, while administration of exogenous 
androgen reinstated the mounting behavior to pre-gonadectomy levels (Davidson, 1966; 
McGinnis et al., 1989). Although testosterone is the most abundant sex steroid hormone 
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in males, administration of its aromatization product, estradiol, has also been shown to 
elicit male-typical behaviors in gonadectomized rats and quails (Clancy et al., 2000; Ball 
et al., 2004). Progesterone has been similarly successful in reversing the effects of 
castration on the sexual behavior of gonadectomized sexually naïve male rats (Wagner, 
2006). Surprisingly, administration of the exogenous non-aromatizable androgen 
dihydrotestosterone does not reinstate sexual behavior in gonadectomized male rats and 
quails, but does so in guinea pigs and whiptail lizards (Alsum et al., 1974; Wade et al., 
1993). 
Sexual behavior in male rodents is not merely a simple effect of hormones but 
requires integration of sensory, integrative, and motor neural pathways. During a 
sociosexual encounter, olfactory information about an opposite-sex partner is carried to 
the olfactory bulb for interpretation. It gets further processed in the medial amygdala, the 
BNST, and the hippocampus, which in turn send projections to the POA, the central site 
of the sensory input integration in males (Kato et al., 2000; Hull et al., 2006). Efferent 
projections from the POA coordinate the CNS response by sending projections to the 
medial prefrontal cortex [mPFC], nucleus accumbens [NAc], as well as the VMN that are 
known to regulate the performance of motivated behaviors and help orchestrate the act of 
copulation (Malsbury et al., 1977; Mathews et al., 1977; Clark et al., 1981; Balfour et al., 
2004; Bell et al., 2009). The CNS input from the POA and the sensory input from the 
male genitalia is integrated in the brainstem nuclei, which send efferent projection to the 
SNB region, effecting a sensory-motor response pattern that results in penile erection and 
male-typical mounting behavior.  
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The importance of sex hormone signaling in the POA is highlighted by lesion 
studies, which inhibit male-typical sexual behavior in all vertebrate males (Paredes, 
2003). Furthermore, c-fos studies have shown that POA is activated in response to 
sociosexual stimuli, such as presence of a female conspecific or following exposure to an 
odor from an estrous female (Heeb et al., 1996; Neal et al., 2007). Expression of steroid 
hormone receptors [Ar and Er] in the POA mediates effects of these hormones on male-
typical behaviors. Additionally, intracranial implantation of androgens into the POA 
elicits mounting behavior in gonadectomized males (Fisher, 1956; Morgantaler et al., 
1978).  
 
Female copulatory behaviors 
In females, estrogen and progesterone are fundamental to the expression of 
copulatory behaviors. Increases in estradiol and progesterone during the follicular phase 
of the estrous cycle cause positive feedback on the HPG axis, resulting in ovulation and 
period of maximum receptivity, called behavioral estrus in rodents (Feder, 1981). In 
ovariectomized females, this positive feedback is abolished, as is ovulation and estrus. 
Administration of exogenous estradiol and progesterone to ovariectomized females in a 
pattern that mimics the natural production of hormones, reverses the effects of 
ovariectomy on sexual behavior and expression of estrogen and progesterone receptors in 
the relevant behavioral brain regions (Pfaff et al., 1994).  
The neural circuitry underlying female copulatory behaviors involve sensory, 
integrative, and motor neural pathways, similar to males. Sensory input from the body 
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flanks and genital region in females is carried to the motor nuclei in the brainstem and is 
then transmitted to hypothalamic, midbrain, and forebrain regions (Pfaff et al., 1994). 
Integration of this input occurs in the ventromedial nucleus of the hypothalamus [VMN], 
which controls lordosis behavior (Malsbury et al., 1977; Mathews et al., 1977; Clark et 
al., 1981). The afferent output from the VMN relays the information to the mPFC, NAc, 
and POA, as well as the motor control centers in the brainstem and spinal cord to 
coordinate the spinal response of dorsiflexion (Balfour et al., 2004; Bell et al., 2009).  
 
Mate choice behaviors  
Beyond the mechanics of copulation, another critical aspect of sociosexual 
interactions is the process of finding and evaluating a mate. Females must both perceive 
and evaluate male cues prior to reaching a mating decision. It is easy to envision that 
mate choice behaviors rest on species-specific exchange of communication signals, used 
to enable an individual to evaluate another as a potential mate. In some species, males are 
known to “advertise” their reproductive fitness through extravagant mating rituals, to 
influence the choice of receptive females (Andersson, 1994). Other cues, including 
auditory and even environmental cues have been shown to influence female mate choice 
(Westneat et al., 2000). The organizational and activational effects of hormones influence 
female mate preference and selectivity (Wilczynski et al., 2010). Developmental studies 
have shown that prenatal treatment with androgens and estrogens alters the mate 
preference for an opposite-sex partner, and results in abnormal mate choices (Matochik et 
al., 1992). Similarly, gonadectomy studies have established the dependence of mate 
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preference behaviors on proper hormone levels during puberty and in adulthoo. Studies 
using neural c-fos activation in a sociosexual context to determine the neural circuitry 
underlying female mate choice behaviors have identified forebrain, midbrain, and 
hypothalamic nuclei, similar to the brain regions regulating masculine and feminine 
copulatory behaviors (Gentner et al., 2001; Hoke et al., 2004; Woolley et al., 2008).  
 
Production of ultrasonic vocalizations  
Acoustic modalities are central in female choice and male mating displays for 
many species (Emerson, 2001; Collins, 2004). Rats vocalize in the ultrasonic range 
[22kHz to about 80kHz], which is above the human hearing capacity [20Hz to 20kHz], 
thus they remain mostly undetected by human observers. Two types of vocalizations are 
emitted by adult Sprague-Dawley rats, categorized by the general frequency of the calls 
as low [22-kHz] and high frequency [50+-kHz] ultrasonic vocalizations [USVs] 
(Brudzynski, 2001; Brudzynski et al., 2002). Evidence from behavioral and 
pharmacological studies suggests that USVs vary depending on social situations and 
experience, and may represent distinct affective states of the vocalizing subject. Adult 
rats emit low-frequency 22-kHz USV when exposed to predators (Blanchard et al., 
1991), or other aversive stimuli, such as unescapable foot-shocks (Vivian et al., 1993; 
Antoniadis et al., 1999; Wohr et al., 2005; Borta et al., 2006). While 22kHz USVs are 
important in certain social situations as described above, I will focus my review on 
50kHZ USVs, which are relevant to my project.  
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50kHZ USVs may serve a communicative function in rodents. They are emitted 
by rodents after removal of their partner from the home cage, or after a rat is separated 
and placed into a new clean cage (Wohr et al., 2008). Thus, the USV calls are thought to 
establish, re-establish, or maintain social contact. 50kHz USVs also occur in affective 
social contexts, including but not limited to juvenile play (Knutson et al., 1998), tickling 
(Burgdorf et al., 2001), social exploratory activity (Brudzynski et al., 2002), and mating 
behavior (McGinnis et al., 2003). Since 50-kHz USVs are also expressed during 
anticipation of copulation (Bialy et al., 2000), play (Knutson et al., 1998), and food 
(Panksepp et al., 2000), it has been suggested that these calls are a sensitive marker for 
reward states and could reflect a positive affective state (Knutson et al., 1999; Panksepp 
et al.).  
Sex steroid hormones are known to influence the production of 50kHz USVs 
(Ball et al., 2003; Moore et al., 2005; Bass et al., 2008). For example, testosterone affects 
vocalizations through actions on behaviorally relevant brain areas [motivational brain 
regions and central vocal motor nuclei] (Yamaguchi, 2002) or through actions on 
peripheral organs involved in USV production [larynx and syrinx] (Taylor, 2010; Pasch 
et al., 2011). Thus, it is not surprising that numerous sex differences in USV production 
exist.  In mongolian gerbils and prairie voles, adult males vocalize more than females 
(Brown et al., 1988; Ma et al., 2014). In another study, male golden hamsters were found 
to produce a higher number of complex, frequency-modulated USV calls compared to the 
females. Entropy of the calls [measure of how energy is dispersed over the frequency] 
was lower in males than in female golden hamsters (Fernandez-Vargas et al., 2015). In 
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the same animals, interquartile bandwidth similarly showed lower measures in males than 
in females (Fernandez-Vargas et al., 2015).  
 
MicroRNAs and sexually dimorphic brain development 
MicroRNAs are small non-coding RNA molecules that exert their effects on gene 
expression by binding to messenger RNA [mRNA], leading to degradation of the mRNA 
molecule or inhibition of protein translation (Kim et al., 2009). The identification of the 
first microRNA was done using forward genetics assays in C. elegans, which uncovered 
a novel, non-coding RNA molecule that mediated the temporal pattern of body formation 
in the worm (Lee et al., 1993; Wightman et al., 1993). Initially believed to be a finding 
confined to worms, the identification of phylogenetically conserved let-7 microRNA in 
rodents spurred an interest in the field of small regulatory RNAs (Reinhart et al., 2000). 
Interestingly, the sexually dimorphic nature of microRNAs was obvious from the initial 
studies. In C. elegans, let-7 is required for worm viability during development, and its 
absence was noted to be lethal [LEThal-7], with females dying at L3 larval stage [early 
developmental stage] and males dying at L4 [later developmental stage]. In the 20 years 
following the identification of the first microRNA, more than 2000 microRNAs have 
been identified in mammalian species, regulating nearly all essential cellular processes in 
development and disease (Olive et al., 2015).  
In the brain, microRNAs are involved in numerous processes, including immune 
responses, apoptosis, and cancer (Kim et al., 2008). They were found to be important in 
neurodevelopment (Conaco et al., 2006; Tan et al., 2012), circadian signaling [e.g. mir-
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132, mir-219] (Cheng et al., 2007), and neurotransmitter and growth factor regulation 
[e.g. mir-7] (Kocerha et al., 2009; Miller et al., 2012; Sakai et al., 2013). The expression 
of some microRNAs is hormone-sensitive, and microRNAs in turn influence the 
expression of genes involved in mediating hormone responses (Klinge, 2009; Rao et al., 
2013).  For example, estradiol treatment altered the microRNA profiles in breast cancer 
cell lines (Klinge, 2009) and in select brain areas in aging rat females (Rao et al., 2013).  
Many microRNAs display sexually dimorphic expression. Studies in fish 
(Bizuayehu et al., 2012), neonatal and adult rodent brains (Olsen et al., 2009; Morgan et 
al., 2012; Murphy et al., 2014), and post-mortem examinations of human brains (Mellios 
et al., 2012) have revealed sex-dependent differences in expression of individual 
microRNAs. For example, in the brains of the teleost fish Hippoglossus hippoglossus 
[Atlantic halibut], mir-451 and mir-9 were higher and lower, respectively in 3-year-old 
females compared to the males (Bizuayehu et al., 2012). Morgan and Bale (Morgan et 
al., 2012) demonstrated that seven microRNAs were sexually dimorphic in the whole 
brains of neonatal rats on postnatal [P] day 0 [day of birth]. Importantly, a single prenatal 
injection of aromatase inhibitor, which inhibits the conversion of testosterone to estradiol, 
feminized microRNA expression in the newborn males on P0. This suggests that some 
microRNAs in the brain affect or are affected by genes regulating the process of sexual 
differentiation. Furthermore, a number of hypothalamic microRNAs are expressed in a 
sexually dimorphic manner during development and are involved in mechanisms 
permitting or leading to puberty onset [e.g., lin28/let-7 family] (Sangiao-Alvarellos et al., 
2013). Finally, studies of post-mortem brains have identified mir-30b, which is estrogen 
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responsive, at significantly lower levels in females compared to males (Mellios et al., 
2012).   
 
Endocrine-disrupting chemicals (EDCs) 
Endocrine-disrupting chemicals (EDCs) are defined as “exogenous chemicals, or 
mixture of chemicals, that interferes with any aspect of hormone action” (Zoeller et al., 
2012). Many effects of EDCs are mediated by hormone receptors such as estrogen 
receptors, androgen receptors, thyroid receptors, and others, which are widely distributed 
in the brain, and thereby perturb endocrine and neurobiological systems. While the 
majority of EDCs tested have estrogenic properties, EDCs can also be anti-estrogenic, 
androgenic, anti-androgenic, or anti-thyroidogenic (Kelce et al., 1997; Schantz et al., 
2001; Zoeller et al., 2005). EDCs may also act via membrane steroid hormone receptors 
(Tokumoto et al., 2007) and thereby act via non-genomic mechanisms. EDCs have been 
also known to affect more global changes in steroid synthesis, metabolism, and 
degradation by influencing the expression of steroidogenic enzymes (Colciago et al., 
2009). Furthermore, EDCs can have neurotoxic effects on neuroendocrine physiology via 
modulation of neurotransmitter systems (Corey et al., 1996; Morse et al., 1996; Seegal et 
al., 2005). Beyond their effects on the reproductive and thyroid axis (Zoeller et al., 2005; 
Dickerson et al., 2007), EDCs can also affect hormone signaling in stress [hypothalamic-
pituitary-adrenal axis], growth [somatotropic axis], lactotrophic axis, and 
neurotransmitter signaling of neural and metabolic peptides (Schantz et al., 2001; Scarth, 
2006).  
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Polychlorinated biphenyls (PCBs) and their effects in the brain 
PCBs are a class of industrial chemicals and known EDCs that were mass-
produced in the United States for 40 years but eventually banned in the late-1970s for 
their toxic effects. Initially these chemicals were employed mostly in encapsulation of 
closed-system apparatuses such as transformers and capacitors (Carpenter, 1998). 
However, their stable chemical compositions and the ability of chemists to alter the 
structure-function relationship by varying their degree of chlorination led to the wide use 
of PCBs as industrial lubricants, adhesives, and sealants (Davila, 1993). Structurally, 
PCBs can be divided into two groups: coplanar and noncoplanar. The structural 
differences dictate functional effects of the PCBs, with the coplanar PCBs acting mostly 
at the steroid hormone receptors, and noncoplanar PCBs affecting neurotransmitter 
regulation (Corey et al., 1996; Morse et al., 1996; Schantz et al., 2001; Seegal et al., 
2005); however the distinction is not absolute. Some coplanar PCBs can also bind aryl 
hydrocarbon receptor, inducing dioxin-like effects (Denison et al., 2003). The degree of 
chlorination of the PCB compounds also dictates their metabolism rate and exposure 
routes. Heavily chlorinated PCBs have a longer half-life both in the environment and 
within the living organisms, while lightly chlorinated PCBs are readily metabolized and 
do not bioaccumulate (Platonow et al., 1975; Hermanson, 1989). Humans and wildlife 
are exposed to heavily chlorinated PCBs via ingestion of contaminated water and 
foodstuffs, primarily fish and meats, while lightly chlorinated PCBs are frequently 
aerosolized and thus exposures occur through inhalation or ingestion after concentration 
in plants.  
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This dissertation will focus on the PCB mixture Aroclor 1221 [A1221], a 
reconstituted mixture of lightly chlorinated PCB congeners that has a relatively short 
half-life, and is weakly estrogenic (Dickerson et al., 2007). This compound has been 
previously shown to have effects on rodent reproductive physiology and behavior 
following prenatal exposure. There are many other EDCs, such as organochlorine 
compounds, bisphenol A, and pesticides, which share some mechanistic features with 
PCBs, but are beyond the scope of this dissertation.   
 
PCBs and the developing hypothalamus 
Several studies have investigated the effects of gestational PCB exposure on brain 
sexual differentiation, highlighting the importance of the critical period of brain 
development. Gestational exposures to PCBs disrupted expression of steroid hormone 
receptors, aromatase activity, and neurotransmitter systems in age-, sex-, and PCB- 
specific manners. Estrogen and progesterone receptors are sensitive targets of gestational 
PCB exposures and may contribute to their effects on brain development. For example, 
gestational exposure to Aroclor 1254 [A1254] increased ERα [estrogen receptor α] and 
decreased PR [progesterone receptor] gene expression in the VMN of embryonic [E20] 
female rats (Lichtensteiger, 2003). Aromatase activity has also been investigated in many 
of the developmental PCB studies. Gestational exposure has been shown to downregulate 
aromatase protein expression and activity in the POA of neonatal [P0] male rats. That 
same study also demonstrated an effect of PCBs at the estrogen receptors, which 
contributed to a hormonal imbalance and resulted in altered brain development (Hany et 
 17 
al., 1999). However, a separate study demonstrated an increase in aromatase gene 
expression at P21 in males exposed to PCBs during prenatal and postnatal development 
[from embryonic day 15 to postnatal day 21] (Colciago et al., 2009). Thus, when 
considering effects of gestational PCBs on gene and protein expression, age at analysis is 
important. The sex of the examined individual is equally important. Short-term 
gestational exposure to A1254 decreased AR protein expression in the hypothalamus of 
embryonic female but not male rats at E20 (Colciago et al., 2006). Other heavily 
chlorinated PCB congeners have also been shown to affect neurotransmitter regulation, 
including serotonergic, dopaminergic, and cholinergic systems at the gene and protein 
expression levels in a sex-specific manner (Corey et al., 1996; Morse et al., 1996; Seegal 
et al., 2005).  
Studies of prenatal exposure to A1221 demonstrated decreased numbers of ERα- 
positive cells in anteroventral perioventricular nucleus [AVPV] in adult female rats at 
postnatal [P] day 60. In the POA of the same females, gestational exposure to A1221 
decreased expression of androgen receptor, insulin-like growth factor 1, NMDA receptor 
subunit NR2b, and transforming growth factor β1, among others (Dickerson et al., 
2011b). In another study, A1221-treated adult females had increased expression of 
kisspeptin, ERα, and prodynorphin genes in the AVPV at P90 (Walker et al., 2014). As a 
whole, the studies in the Gore lab and others suggest that gestational exposures to PCBs 
disrupt the normal pattern of gene and protein expression in the developing brain.   
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PCB effects on adult behaviors  
PCB exposures during development have been associated with changes in adult 
behaviors related to social and sexual interactions. Gestational exposure to A1221 
disrupted sexual and social behavior in adult rats. This was manifested as an increase in 
time to mate in paced mating experiments in exposed females (Steinberg et al., 2007), 
and by decreased time spent nose-touching with same-sex gonadecomized males in 
sociability paradigm in exposed males (Reilly, under review). Exposure to other PCBs 
has shown similar effects on reproductive and social behaviors in rats. For instance, 
female rats that were gestationally exposed to PCBs showed depressed sexual receptivity 
(Wang et al., 2002) and altered timing of mating events (Chung et al., 2001). In another 
study, juvenile as well as adult social behaviors were altered in gestational PCB-exposed 
rats (Jolous-Jamshidi et al., 2010). Cummings et al demonstrated that females exposed to 
PCBs shortly after birth had decreased interest in males in a partner preference test 
(Cummings et al., 2008). Furthermore, maternal behaviors in rodents and play behaviors 
in humans and rodents were disrupted by gestational PCB exposures (Cummings et al., 
2005; Bell, communication). Additionally, PCBs affected cognitive development 
(Stewart et al., 2003), hyperactivity-associated behaviors (Neugebauer et al., 2015), and 
taste preference (Kaya et al., 2002). In summary, there is a robust literature for 
developmental effects of PCB exposures on a variety of behaviors, which may be due to 
PCB effects on developing neural networks. 
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PCBs and other EDC effects on microRNA expression 
The effects of EDCs on microRNAs is a burgeoning field that includes studies on 
several tissue and cell types, but there has been little research on the nervous system and 
the developing brain. Some work has been conducted in cell lines on the EDC bisphenol 
A [BPA]. In in vitro immortalized cytotrophoblast placental cell lines, BPA strongly 
induced mir-146a expression (Avissar-Whiting et al., 2010), and in human MCF-7 breast 
cancer cell line, BPA treatment altered the expression of multiple microRNAs, including 
mir-21 (Tilghman et al., 2012). Effects of another estrogenic EDC, nonylphenol, were 
investigated in mouse Sertoli cell lines in which a number of microRNAs were up- or 
down-regulated (Choi et al., 2011). In animal studies, oral BPA given to adult male rats 
for two months caused alterations in the transcriptional profiles of mRNA and microRNA 
expression within the penile shafts and resulted in a moderate corporal veno-occlusive 
erectile dysfunction (Kovanecz et al., 2014). 
Relatively little work has been published on EDCs and microRNAs in the brain, 
either in vitro or in vivo. Lesiak et al investigated the effects of PCB 95 on microRNA 
expression in primary dissociated rat hippocampal cultures and found that neurotoxic 
effects of PCB 95 were mediated via mir-132 upregulation, which in turn suppressed the 
translation of p250GAP, a negative regulator of synaptogenesis (Lesiak et al., 2014). Oral 
RDX, a common environmental contaminant, fed to adult mice for 28 days altered 
microRNA expression in the liver and brain (Zhang et al., 2009). These studies point to 
the susceptibility of microRNA signaling to endocrine disruption.  
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Summary and goals of this dissertation 
Taken together, these data emphasize the importance of sexual dimorphisms in 
reproductive physiology and outline their sensitivity to endocrine disruption. A few 
global conclusions can be made. First, low-dose EDC exposures during the sensitive 
perinatal developmental periods underlie the field the developmental [fetal] basis of adult 
disease and will be the focus of this dissertation. This concept includes a potentially long 
latency from exposure to disease or dysfunction. Second, the examination of sexually 
dimorphic endpoints provides a sensitive framework for discerning the organizational 
effects of hormones and EDCs during development on microRNAs, genes, and adult 
behaviors in both sexes. Finally, and of particular relevance to humans, due to the reality 
of world-wide contamination, humans are primarily exposed to non-occupational low-
level mixtures of various chemicals. Thus, this dissertation will focus on gestational 
exposure to low-levels PCBs, and analyze sexually dimorphic endpoints that are related 
to brain sexual differentiation.  
In my dissertation, the effects of A1221 are investigated during the perinatal 
period when levels of endogenous hormones vary precipitously and are sex-specific, and 
the developing fetus exhibits heightened sensitivity to even slight changes in the 
hormonal milieu. Therefore, introduction of exogenous hormone mimics such as A1221 
allows for the investigation of perturbation of hormone-dependent brain sexual 
differentiation and its influence on permanent organizational effects on the developing 
neuroendocrine system, affecting physiology and behavior in adulthood. 
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Chapter 2 examines the effects of sex and age on the expression of hormone-
sensitive hypothalamic microRNAs during postnatal development and investigates the 
effects of endocrine disruption on microRNA expression. This work is the first 
developmental profile of hormone-sensitive microRNAs in two hypothalamic nuclei, the 
medial preoptic nucleus and ventromedial nucleus of the hypothalamus. Additionally, to 
my knowledge, there are no published studies that have examined the effects of 
gestational EDCs on microRNA expression.  
Chapter 3 investigates the effects of gestational PCB exposure on sexually-
dimorphic adult behaviors and gene expression relevant brain nuclei. Two sexually 
dimorphic adult behaviors examined are the production of ultrasonic vocalizations and 
sociosexual preference behaviors. The focus of the molecular work in Chapter II is the 
examination of gene expression changes in two sexually dimorphic hypothalamic brain 
regions, the MPN and VMN, known for their involvement in reproductive physiology 
and behavior. Relationships between behaviors and gene expression are also determined.  
In summary, the effects of PCBs on the developing HPG axis range from 
disruptions of neural differentiation of sexually dimorphic brain regions, to alterations in 
gene and protein expression, steroidogenic enzymatic activity, serum hormone levels, to 
interference with adult reproductive behaviors. From the studies described herein, it can 
be concluded that the developing neuroendocrine system constitutes a sensitive target of 
endocrine disruption. This dissertation will provide novel insight into the mechanisms by 
which PCBs cause neuroendocrine dysfunction.   
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Chapter 2: Sexually dimorphic effects of gestational endocrine-
disrupting chemicals on microRNA expression in the developing rat 
hypothalamus 
 
Abstract 
MicroRNAs are small non-coding RNAs involved in post-transcriptional 
regulation of gene expression. This study had two goals: first, to examine expression of 
eight microRNAs in two hypothalamic regions for developmental change and possible 
sexual dimorphisms, and second, to investigate whether low-level gestational exposures 
to environmental endocrine-disrupting chemicals [EDCs] altered these expression 
patterns. Pregnant Sprague-Dawley rats were injected on gestational days 16 and 18 with 
vehicle [DMSO], estradiol benzoate [EB, 50 μg/kg], or a weakly estrogenic mixture of 
polychlorinated biphenyls [A1221, 1 mg/kg]. Pups were born and littermates were 
euthanized on postnatal days [P] 15, 30, 45, or 90. The medial preoptic nucleus [MPN] 
and ventromedial nucleus [VMN] of the hypothalamus were assayed for expression of 
selected microRNAs [let-7a, let-7b, mir-124a, mir-132, mir-145, mir-219, mir-7, mir-9]. 
MicroRNAs showed robust developmental changes in both regions, and most were 
sexually dimorphic in the MPN, but not the VMN. In the MPN, EDC effects on 
microRNA expression were sex and age-specific. In females, most microRNAs had 
higher expression levels in PCB- and EB-exposed animals compared to vehicle during 
the pubertal transition [P30]. In males, microRNA levels were lower in PCB- than 
vehicle-exposed groups in adulthood [P90]. There were fewer effects of treatment in the 
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VMN. In silico target prediction analysis was used to select mRNA targets of the affected 
microRNAs for gene expression analysis by qPCR [Ar, Pgr, Ppara, Igf1r, Grin2a, Clock, 
Lin28b, Lepr]. Modest effects of treatment were found but no clear relationship with 
microRNAs was identified.  In summary, hypothalamic microRNAs are sexually 
dimorphic and regulated by EDCs in a sex-, developmental age-, and brain region-
specific manner.  
 
Introduction 
During the period of brain sexual differentiation in gestation and early postnatal 
life, gonadal hormones organize the development of brain structures that govern sex-
typical physiology and behavior (Phoenix et al., 1959; Wallen, 2009). Exposure to 
exogenous hormones or endocrine-disrupting chemicals [EDCs] during this life stage 
results in structural and functional neurobiological changes (Diamanti-Kandarakis et al., 
2009). The underlying molecular pathways for these effects are varied, and can involve 
gene and protein expression, apoptosis, neurogenesis, and molecular epigenetic 
mechanisms such as DNA methylation and histone modifications (Dolinoy et al., 2007; 
Bredfeldt et al., 2010; Dickerson et al., 2011a; Dickerson et al., 2011b; Komada et al., 
2012).  
A recently identified player in brain sexual differentiation are microRNAs, a 
family of small regulatory noncoding RNAs that bind to the 3’-untranslated region of a 
target mRNA, causing mRNA translational repression and/or degradation (Filipowicz et 
al., 2005). The expression of some microRNAs is hormone-sensitive, and microRNAs, in 
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turn, influence the expression of genes involved in mediating hormone responses (Klinge, 
2009; Rao et al., 2013). Individual microRNAs are expressed in the nervous system in a 
region- and development-specific manner (Olsen et al., 2009; Ziats et al., 2014). Some, 
such as mir-124a and mir-9 are important in neurodevelopment (Conaco et al., 2006; Tan 
et al., 2012), and are highly expressed in the hypothalamus (e.g. mir-7, mir-132, mir-219) 
(Kocerha et al., 2009; Miller et al., 2012; Sakai et al., 2013). Furthermore, a number of 
hypothalamic microRNAs are expressed in a sexually-dimorphic manner during 
development [e.g., lin28/let-7 family] (Sangiao-Alvarellos et al., 2013). Although 
research on links between prenatal hormones on microRNA expression on the brain is 
limited, work on prenatal or maternal stress demonstrates effects on expression of a 
subset of these and other microRNAs (Morgan et al., 2011; Zucchi et al., 2013). 
The effects of prenatal EDCs on developmental expression of microRNAs have 
not been studied in the hypothalamus, but their effects have been shown in other tissues 
including mouse Sertoli cells (Choi et al., 2011), whole brains, and livers (Zhang et al., 
2009); rat penile shafts (Kovanecz et al., 2014) and hippocampal cultures (Lesiak et al., 
2014); and human breast carcinoma (Tilghman et al., 2012; Teng et al., 2013) and 
placental cell lines (Avissar-Whiting et al., 2010). In the current study, we addressed 
whether a class of prenatal EDCs affect the expression of microRNAs during brain sexual 
differentiation following prenatal exposure of rats to A1221, a mixture of polychlorinated 
biphenyls [PCBs] that has previously been shown to perturb expression of sexually 
dimorphic genes in the brain and cause reproductive and behavioral phenotypic changes 
in adulthood (Steinberg et al., 2007; Steinberg et al., 2008; Dickerson et al., 2011a; 
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Dickerson et al., 2011b; Walker et al., 2013; Walker et al., 2014). We also assayed 
several mRNA targets of the microRNAs. Work was conducted on two sexually-
dimorphic, hormone-sensitive hypothalamic regions involved in reproductive physiology 
and behavior (Malsbury et al., 1977; Mathews et al., 1977; Clark et al., 1981; Hoshina et 
al., 1994; Kato et al., 2000; Hull et al., 2006), the medial preoptic nucleus [MPN] and the 
ventromedial nucleus [VMN].  
 
Materials and methods 
Animals and treatments 
All protocols were performed in accordance with the guidelines from the National 
Institute of Health Guide for the Care and Use of Laboratory Animals and approved by 
the Institutional Animal Care and Use Committee at the University of Texas at Austin. 
Brain regions were collected from rats used for a published study on effects of EDCs on 
gene expression in other hypothalamic regions, and detailed husbandry is provided in that 
report (Walker et al., 2014). In brief, Sprague-Dawley dams and sires [Harlan, Houston, 
TX] were purchased, and provided low phytoestrogen Harlan Teklad 2019 Global Diet 
ad libidum for at least 2 weeks prior to mating. The first day of successful pregnancy was 
termed embryonic day [E] 0. At the beginning of the third trimester, corresponding to the 
onset of the period of hypothalamic sexual differentiation, on E16 and E18, the dams 
were injected intraperitoneally with one of three treatments: vehicle [100% 
dimethylsulfoxide [DMSO] Sigma number D4540; Sigma, St Louis, Missouri]; 50 μg/kg 
estradiol benzoate [EB; Sigma number E8515; or 1 mg/kg A1221 [AccuStandard, New 
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Haven, Connecticut, number C221N], all in 0.1 ml volume. The dosage, route, and timing 
of exposure were based on published work showing effects on reproductive function and 
gene expression in exposed rats (Steinberg et al., 2007; Steinberg et al., 2008; Dickerson 
et al., 2011a; Dickerson et al., 2011b; Walker et al., 2013; Walker et al., 2014).  
 
Brain tissue collection and storage 
On P15, P30, P45, and P90, one male and one female littermate were euthanized 
two - three hours before lights out by rapid decapitation. Trunk blood was collected, 
allowed to clot, and centrifuged to collect the serum for hormone assays. Body and organ 
weights were also measured at euthanasia. The brains were dissected and cut into one 
mm coronal sections using a rat brain matrix, and bilateral micropunches of MPN and 
VMN were collected using a Palkovits punch [0.98 mm in diameter] (Walker et al., 
2013). Post-pubertal females were monitored daily by vaginal smears and euthanized on 
proestrus. Ten animals per group were used for microRNA and mRNA gene expression 
studies. 
 
RNA isolation, preparation, and real-time PCR 
Total RNA was isolated from frozen MPN and VMN punches of individual male 
and female rats using a mirVana microRNA isolation kit according to the manufacturer’s 
protocols [catalog no. AM1560, Life Technologies, Carlsbad, CA]. All RNA samples 
were analyzed for quantity by Nanodrop spectrophotometry and run on the Bioanalyzer 
 27 
2100 [catalog no. 5067-1511, Agilent Technologies, Santa Clara, CA] to assess RNA 
purity and integrity. Only RNA samples with the RIN of 8 or higher were used.  
Total RNA [200 ng total for mRNA, 10 ng for microRNA] was used to generate 
cDNA. Taqman MicroRNA Reverse Transcription kit [catalog no.4366596] with Taqman 
RT primers [catalog no. 4440886, Life Technologies] and high-capacity cDNA reverse 
transcription kit with RNase inhibitor [catalog no. 4374966, Life Technologies] were 
used for microRNA and mRNA, respectively, according to the manufacturer’s 
recommended protocols.  
For microRNA analysis, we selected eight specific microRNA assays based on 
evidence for their expression in the hypothalamus [let-7a, let-7b, mir-124a, mir-132, mir-
145, mir-219, mir-7, mir-9] (Cheng et al., 2007; Davis et al., 2012; Sakai et al., 2013). 
Due to the small amount of starting material, only biological replicates were used for 
analysis. Technical replicates were run prior to the experiment to validate each assay and 
intra-assay CV was determined to be <2%.  For these and other assays, a no-reverse 
transcription control was run to confirm the absence of genomic DNA contamination, and 
a positive control was run on each plate to control for inter-plate variability. Inter-plate 
variability was <4%.  
Messenger RNA targets were selected based on in silico predictions of gene 
targets for the microRNAs [see below] (Dickerson et al., 2011a; Dickerson et al., 2011b; 
Casati et al., 2013; Walker et al., 2013; Walker et al., 2014). We conducted real-time 
PCR analysis using Taqman primer and probe sets for subsets of 8 genes [Ar, Clock, 
Lepr, Lin28b, Ppara, Grin2a, Igf1r, Ar, Pgr] based on microRNA results by sex and 
 28 
brain region. Samples were run in triplicate and any of the triplicates with a value of 1.5 
SD above the mean of that animal was removed, with up to 2 samples per gene removed. 
None of the triplicates had a coefficient of variation greater than 2%.  
 Real-time PCR for microRNA and mRNA analysis was carried out on an ABI 
ViiA7 using Applied Biosystems TaqMan Universal PCR Master Mix [catalog no. 
4324018, Life Technologies] and using the following run parameters: 95°C for 10 
minutes, 50 cycles of 95°C for 15 seconds, and 60°C for 1 minute.  
 
In silico analysis of combinatorial microRNA activity  
To determine the potential mRNA targets of the microRNAs that were affected by 
sex, treatment, or age, we used the prediction program ComiR, chosen for its 
combinatorial approach in gene target identification, to generate a list of mRNA targets 
for each region and sex (Coronnello et al., 2012; Coronnello et al., 2013). The selected 
genes were verified for the number of binding sites of the predicted microRNAs using 
Targetscan. The bioinformatic analysis was done across age in four groups: female MPN, 
male MPN, female VMN, and male VMN. The microRNA groups used for ComiR 
analysis were mir-145 and mir-7 in female MPN; mir-132, mir-219, mir-9, mir-145, let-
7a, and mir-124a in male MPN; let-7a, mir-124a, and mir-219 in female VMN; mir-124a 
in male VMN. DAVID was used to provide biological interpretation of the large gene 
lists generated by ComiR and annotate them by gene families and function (Huang da et 
al., 2009a; Huang da et al., 2009b). Putative targets were chosen for further analysis 
based on their known role in neuronal function and their algorithm score, as determined 
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by the computer modeling programs (Huang da et al., 2009a; Huang da et al., 2009b; 
Coronnello et al., 2012; Coronnello et al., 2013).  
 
Hormone assays 
Serum testosterone and estradiol levels in the same rats used herein have 
previously been measured, and assay characteristics and results were published 
previously (Walker et al., 2014). For the current study, hormone concentrations were 
used for correlation analysis with microRNA and mRNA levels in the MPN and VMN in 
bionetwork analyses.           
 
Statistics 
All microRNA and mRNA data [raw CT values] were normalized within sex to 
the median of the DMSO P15 group in an R statistical package for qPCR analysis which 
utilized a generalized linear mixed model with Poisson-lognormal errors and a Bayesian 
Marco Chain Monte Carlo sampling scheme (Matz et al., 2013). All data were normally 
distributed and homoscedastic. The statistical analysis was done using the multiple 
comparisons analysis of variance [MANOVA], which addresses the false discovery rates 
of multiple comparisons, to compare each endpoint [genes and microRNAs] using sex, 
age, and treatment as independent variables. The R package was run in naïve form, 
without specifying any control genes, and the statistical significance was set at P < 0.05. 
Post hoc analyses included t-test for sex effect and Tukey HSD for treatment effect and 
interactions. MicroRNA expression data were graphed as mean fold-change ± standard 
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error of the mean using DMSO female as a reference group. mRNA expression data were 
graphed as mean fold-change ± standard error of the mean using DMSO group within sex 
as a reference group. 
 
Bionetwork analysis  
To examine possible relationships among microRNAs, genes, and serum estradiol 
and testosterone levels, the latter from a companion paper already published on these rats 
(Walker et al. 2014) throughout development, the data were analyzed using a bootstrap 
technique, as previously reported (Walker et al., 2013; Walker et al., 2014).  
 
Results    
Effects of sex, age, and EDC treatment on microRNA expression in the MPN 
Effects of sex, age, treatment, and their interactions, on microRNA expression in 
the MPN were analyzed (Figure 2.1). Detailed statistics for mir-132, mir-219, mir-7, and 
mir-9 are presented in Table 2.1 and statistics for mir-145, let-7a, let-7b, and mir-124a 
are shown in Table 2.2. In the MPN, five microRNAs showed significant sex effects, 
with three higher in females than males [mir-219, mir-7 (both, p<0.05), mir-145 
(p<0.005)], and two higher in males than females [mir-9 (p<0.001) and let-7b (p<0.05)]. 
Significant age effects were found for six microRNAs, all of which increased with 
advancing age [mir-132, mir-219, mir-7, mir-145, let-7a, let-7b (all p<0.005)]. Mir-9 
expression decreased significantly with age (p<0.005). Only mir-124a showed no age-
related changes in the MPN.  
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The effects of prenatal treatment in the MPN were age- and sex-specific. A1221 
and EB females had significantly increased expression of six microRNAs and this was 
specific to one age, P30 [mir-219, mir-132, mir-7, mir-145, let-7a, and mir-124a (all 
p<0.005)]. Expression of mir-132 and mir-9 was increased by EB at P15 (both p<0.005), 
and mir-7 was decreased at P45 in the EB females. In the males, A1221 animals had 
decreased expression of 6 microRNAs, specifically at P90 [mir-132, mir-219, mir-9, mir-
145, let-7a, and mir-124a (all p<0.005)]. Mir-145 was decreased in A1221 males 
(p<0.005) and let-7b was increased (p<0.005) at P45.  EB males had decreased 
expression of mir-145 at P90 (p<0.005). EB males had increased expression of mir-219, 
mir-7, mir-9, and let-7b (all p<0.005) at P45.  
 
Effects of sex, age, and EDC treatment on microRNA expression in the VMN 
In the VMN, main effects of sex, age, treatment, and their interactions on 
microRNA expression were examined (Figure 2.2; detailed statistics for mir-132, mir-
219, mir-7, and mir-9 are presented in Table 2.3 and statistics for mir-145, let-7a, let-7b, 
and mir-124a are shown in Table 2.4). Only one sex difference was found, for mir-219 
(p<0.005), with expression higher in the females compared to males. All 8 microRNAs 
increased expression with advancing age in the VMN (p<0.005).  
The effects of prenatal treatment in the VMN were age- and sex-specific. In the 
A1221 females, mir-124a expression was increased at P15 (p<0.005), and let-7a 
expression was decreased at P90 (p<0.005). EB females had increased expression at P15 
of mir-219 (p<0.0005) and mir-124a (p<0.005). In the males, A1221 and EB rats had 
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increased expression at P30 of mir-9 and let-7b (both p<0.005), and decreased expression 
of mir-219 at P45 (p<0.0005). A1221 males also had decreased expression of mir-124a at 
P90 (p<0.005). 
 
In silico analysis of combinatorial microRNA activity  
In silico analysis was conducted separately for the female MPN, female VMN, 
male MPN, and male VMN, to identify mRNA targets. The microRNA groupings were: 
mir-132, mir-219, mir-9, mir-145, let-7a, and mir-124a in male MPN; mir-145 and mir-7 
in female MPN; let-7a, mir-124a, and mir-219 in female VMN; mir-124a in male VMN. 
To provide an example, the DAVID results in the males in the MPN are discussed. 
DAVID analysis of the combined male MPN target list from ComiR yielded 158 clusters, 
with 25 significantly enriched (score >1). Annotation clusters 1 and 2 (enrichment scores 
of 2.5) had the gene clusters that belonged to the nuclear-hormone receptor, ligand/DNA-
binding receptors families. The pathways included post-trascriptional silencing by small 
RNAs, nuclear receptor transcription pathway and nuclear receptors among the top six 
which highlighted the hormone regulatory function of chosen microRNA. The genes 
chosen for qPCR in each group are shown in Table 2.5.   
 
Effects of age and EDC treatment on mRNA expression in the MPN  
Because gene targets were different in males and females, analyses were 
conducted separately for each sex and region. In the female MPN, gene expression 
decreased with increasing developmental age for Grin2a and Igf1r (p<0.005 for both, 
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Figure 2.3A, 2.3B).  A main effect of treatment was also found for both genes, with 
decreased expression of Grin2a and Igf1r in the A1221-treated females compared to 
DMSO females (p<0.005). There were no treatment by age interactions. In the male MPN 
(Figure 2.3C, 2.3D, 2.3E), expression of Ar, Pgr, and Ppara decreased with 
developmental age (all p < 0.005). A main effect of treatment was found for Pgr and 
Ppara, with decreased expression in A1221 compared to DMSO males (both p < 0.005). 
A treatment by age interaction for A1221 was also found, with decreased expression of 
Ppara at P15 (p<0.005).  
 
Effects of age and EDC treatment on mRNA expression in the VMN  
Age and treatment effects on mRNA gene expression were found in the VMN 
(Figure 2.4; detailed statistics in Table 2.6). In the females (Figure 2.4A, 2.4B, 2.4C, 
2.4D), significant developmental increases were found for Lepr, Clock, and Ppara (all p 
< 0.005). Main effect of EB treatment were found, with increased gene expression of 
Clock in the female VMN (p<0.001). There were also treatment by age interactions in the 
female VMN for prenatal EB treatment, with increased expression at P45 of Lepr and  
Clock (both p < 0.005). In the males (Figure 2.4E, 2.4F), Ar expression increased with 
age (p<0.005) and Clock (p<0.005) decreased with age. Treatment by age interactions of 
prenatal A1221 and EB treatments were also found. Specifically, A1221 and EB males 
had decreased expression of Ar (p<0.0005), and Clock expression was decreased in 
A1221 males at P90 (p<0.05). 
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Bionetwork analysis of microRNAs, mRNAs, and hormones    
Bionetwork analysis was conducted using Pearson’s correlation coefficients to 
enable investigation into relationships among microRNAs, genes, and hormones, and to 
determine whether there were inverse relationships between microRNAs and their 
predicted mRNA targets. Only positive correlations were detected, with the correlation 
strength ranging from 0.5 to 1 (Figures 2.5, 2.6). The networks were examined within 
each region, and the numbers of identical (same as vehicle) and novel (different from 
vehicle) correlations were counted in A1221 and EB networks. In the females, there were 
few differences in correlations with treatment in either brain region (Figure 2.5). For 
example, in the female MPN, mir-132 and mir-145, mir-124a and let-7b, and mir-9 and 
let-7a, were significantly correlated in all three treatment groups. In the female VMN, 
mir-132 and mir-219, mir-132 and mir-7, and others, showed similar correlations across 
the different treatment networks. By contrast, males showed more differences between 
networks with treatment (Figure 2.6). In the MPN, the A1221 and EB males had 
correlations not seen in the DMSO males, such as for mir-124a, mir-7, let-7b, Ar, Ppara, 
and Pgr. The male VMN networks did not differ substantially by treatment. Interestingly, 
serum estradiol concentrations were positively correlated with mir-219 in both the male 
MPN and VMN of all treatment groups, and estradiol and mir-132 were correlated in four 
of these six groups (Figure 2.6). In females (Figure 2.5) estradiol was also correlated 
with mir-219 in the three treatment groups in the MPN, and in the DMSO and A1221 
VMN. 
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Figures and tables  
 
Figure 2.1: Developmental profiles of mir-132, mir-219, mir-7, mir-9, mir-145, let-7a, 
let-7b and mir-124a are shown in the MPN of female and male rats. Main effects of age, 
sex, and treatment are shown. Post-hoc effects of treatment are indicated when the sex by 
treatment by age interaction was significant. *p < 0.05, A1221 vs. DMSO at the same 
age; +p < 0.05, EB vs. DMSO at the same age. Significant age effects (p < 0.05) are 
shown as: a, P15 vs P30; b, P15 vs P45; c, P15 vs P90; d, P30 vs P45; e, P30 vs P90. 
Abbreviation: Trt, Treatment.  
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Figure 2.2: Developmental profiles of mir-132, mir-219, mir-7, mir-9, mir-145, let-7a, 
let-7a, and mir-124a are shown in the VMN of male and female rats. Main effects of age, 
sex, and treatment are shown. Post-hoc effects of treatment are indicated when the sex by 
treatment by age interaction was significant. *p < 0.05, A1221 vs. DMSO at the same 
age; +p < 0.05 EB vs. DMSO at the same age. Significant age effects are shown as: a, 
P15 vs P30; b, P15 vs P45; c, P15 vs P90; e, P30 vs P90; f, P45 vs P90, p<0.05 for all. 
Abbreviations: Trt, Treatment.  
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Figure 2.3: mRNA expression is shown in the MPN of females (A-B) and males (C-E). 
Main effects of age and treatment are shown. Significant age effects (p < 0.05) are shown 
as: b, P15 vs P45; c, P15 vs P90; d, P30 vs P45; e, P30 vs P90; f, P45 vs P90. 
Abbreviations: Trt, Treatment.  
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Figure 2.4: mRNA expression is shown in the VMN of females (A-D) and males (E-F). 
Main effects of age and treatment are shown. Post-hoc effects of treatment are indicated 
when the treatment by age interaction was significant. *p < 0.05 A1221 vs. DMSO at the 
same age; +p < 0.05 EB vs. DMSO at the same age. Significant age effects (p < 0.05) are 
shown as: a, P15 vs P30; b, P15 vs P45; c, P15 vs P90; d, P30 vs P45; e, P30 vs P90; f, 
P45 vs P90. Abbreviations: Trt, Treatment.  
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Figure 2.5: Cytoscape analysis of microRNAs, genes, and hormones for the three 
treatment groups in the females, collapsed across development, in the MPN (A-C) and 
VMN (D-F). Abbreviations: E2, estradiol, T, testosterone.  
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Figure 2.6: Cytoscape analysis of microRNAs, genes, and hormones for the three 
treatment groups in the males, collapsed across development, in the MPN (A-C) and 
VMN (D-F). Abbreviations: E2, estradiol, T, testosterone. 
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Table 2.1. Statistical results of multiple comparisons ANOVA using sex, age, and 
treatment as independent variables for mir-132, mir-219, mir-7, and mir-9 microRNA 
analysis in the MPN. Significant post-hocs for treatment when main effect of treatment or 
sex X treatment X age interaction was significant are indicated in bold.  
microRNA Tissue Main 
effect/Interaction 
F P Degree 
of 
freedom 
Residual 
degree of 
freedom 
mir-132 MPN Sex 1.21 0.27 1 207 
  Treatment 11.07 0.001 2 207 
  Age 134.00 0.001 3 207 
  Sex X Treatment 15.20 0.001 2 207 
  Sex X Age 0.95 0.41 3 207 
  Treatment X Age 2.81 0.01 6 207 
  Sex X Treatment X 
Age 
4.36 0.0003 6 207 
mir-219 MPN Sex 5.28 0.02 1 207 
  Treatment 13.59 0.001 2 207 
  Age 323.05 0.001 3 207 
  Sex X Treatment 18.13 0.001 2 207 
  Sex X Age 3.04 0.02 3 207 
  Treatment X Age 13.95 0.001 6 207 
  Sex X Treatment X 
Age 
8.33 0.001 6 207 
mir-7 MPN Sex 4.56 0.03 1 207 
  Treatment 3.36 0.001 2 207 
  Age 30.61 0.001 3 207 
  Sex X Treatment 6.65 0.001 2 207 
  Sex X Age 11.27 0.001 3 207 
  Treatment X Age 9.54 0.001 6 207 
  Sex X Treatment X 
Age 
24.04 0.001 6 207 
mir-9 MPN Sex 11.65 0.0007 1 207 
  Treatment 7.43 0.0007 2 207 
  Age 28.62 0.001 3 207 
  Sex X Treatment 4.90 0.008 2 207 
  Sex X Age 3.42 0.01 3 207 
  Treatment X Age 5.15 0.001 6 207 
  Sex X Treatment X 
Age 
11.54 0.001 6 207 
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Table 2.2. Statistical results of multiple comparisons ANOVA using sex, age, and 
treatment as independent variables for mir-145, let-7a, let-7b, and mir-124a microRNA 
analysis in the MPN. Significant post-hocs for treatment when main effect of treatment or 
sex X treatment X age interaction was significant are indicated in bold.  
microRNA Tissue Main 
effect/Interaction 
F P Degree of 
freedom 
Residual 
degree of 
freedom 
mir-145 MPN Sex 9.18 0.002 1 207 
  Treatment 7.61 0.0006 2 207 
  Age 22.35 0.001 3 207 
  Sex X Treatment 21.84 0.001 2 207 
  Sex X Age 5.61 0.001 3 207 
  Treatment X Age 10.52 0.001 6 207 
  Sex X Treatment X 
Age 
11.41 0.001 6 207 
let-7a MPN Sex 2.30 0.1 1 207 
  Treatment 5.57 0.004 2 207 
  Age 17.70 0.001 3 207 
  Sex X Treatment 4.00 0.01 2 207 
  Sex X Age 1.08 0.3 3 207 
  Treatment X Age 5.61 0.001 6 207 
  Sex X Treatment X 
Age 
9.77 0.001 6 207 
let-7b MPN Sex 4.72 0.03 1 207 
  Treatment 10.23 0.001 2 207 
  Age 20.30 0.001 3 207 
  Sex X Treatment 0.85 0.4 2 207 
  Sex X Age 1.75 0.1 3 207 
  Treatment X Age 5.80 0.001 6 207 
  Sex X Treatment X 
Age 
6.70 0.001 6 207 
mir-124a MPN Sex 0.79 0.3 1 207 
  Treatment 2.50 0.08 2 207 
  Age 2.58 0.05 3 207 
  Sex X Treatment 9.06 0.0001 2 207 
  Sex X Age 3.80 0.01 3 207 
  Treatment X Age 5.62 0.001 6 207 
  Sex X Treatment X 
Age 
6.81 0.001 6 207 
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Table 2.3. Statistical results of multiple comparisons ANOVA using sex, age, and 
treatment as independent variables for mir-132, mir-219, mir-7, and mir-9 microRNA 
analysis in the VMN. Significant post-hocs for treatment when main effect of treatment 
or sex X treatment X age interaction was significant are indicated in bold.  
microRNA Tissue Main 
effect/Interaction 
F P Degree 
of 
freedom 
Residual 
degree of 
freedom 
mir-132 VMN Sex 0.06 0.8 1 216 
  Treatment 2.46 0.08 2 216 
  Age 297.66 0.001 3 216 
  Sex X Treatment 0.10 0.9 2 216 
  Sex X Age 4.11 0.007 3 216 
  Treatment X Age 2.85 0.01 6 216 
  Sex X Treatment X 
Age 
2.06 0.05 6 216 
mir-219 VMN Sex 31.43 0.001 1 216 
  Treatment 0.46 0.6 2 216 
  Age 689.63 0.001 3 216 
  Sex X Treatment 16.64 0.001 2 216 
  Sex X Age 3.80 0.01 3 216 
  Treatment X Age 9.93 0.001 6 216 
  Sex X Treatment X 
Age 
4.76 0.0001 6 216 
mir-7 VMN Sex 0.55 0.4 1 216 
  Treatment 3.73 0.02 2 216 
  Age 81.82 0.001 3 216 
  Sex X Treatment 0.12 0.8 2 216 
  Sex X Age 1.75 0.1 3 216 
  Treatment X Age 7.16 0.001 6 216 
  Sex X Treatment X 
Age 
0.36 0.8 6 216 
mir-9 VMN Sex 1.60 0.2 1 216 
  Treatment 14.97 0.001 2 216 
  Age 70.03 0.001 3 216 
  Sex X Treatment 0.42 0.6 2 216 
  Sex X Age 7.16 0.0001 3 216 
  Treatment X Age 3.28 0.004 6 216 
  Sex X Treatment X 
Age 
8.14 0.001 6 216 
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Table 2.4. Statistical results of multiple comparisons ANOVA using sex, age, and 
treatment as independent variables for mir-145, let-7a, let-7b, and mir-124a microRNA 
analysis in the VMN. Significant post-hocs for treatment when main effect of treatment 
or sex X treatment X age interaction was significant are indicated in bold. 
microRNA Tissue Main 
effect/Interaction 
F P Degree 
of 
freedom 
Residual 
degree of 
freedom 
mir-145 VMN Sex 0.11 0.7 1 216 
  Treatment 0.87 0.4 2 216 
  Age 85.02 0.001 3 216 
  Sex X Treatment 2.19 0.1 2 216 
  Sex X Age 2.98 0.03 3 216 
  Treatment X Age 2.98 0.007 6 216 
  Sex X Treatment X 
Age 
5.02 0.001 6 216 
let-7a VMN Sex 1.37 0.2 1 215 
  Treatment 3.06 0.04 2 215 
  Age 23.78 0.001 3 215 
  Sex X Treatment 4.18 0.01 2 215 
  Sex X Age 3.21 0.02 3 215 
  Treatment X Age 11.86 0.001 6 215 
  Sex X Treatment 
X Age 
5.78 0.001 6 215 
let-7b VMN Sex 1.42 0.2 1 216 
  Treatment 14.86 0.001 2 216 
  Age 69.74 0.001 3 216 
  Sex X Treatment 0.44 0.4 2 216 
  Sex X Age 7.43 0.001 3 216 
  Treatment X Age 3.30 0.003 6 216 
  Sex X Treatment 
X Age 
8.49 0.001 6 216 
mir-124a VMN Sex 0.79 0.3 1 216 
  Treatment 2.30 0.1 2 216 
  Age 22.43 0.001 3 216 
  Sex X Treatment 2.12 0.1 2 216 
  Sex X Age 9.80 0.001 3 216 
  Treatment X Age 4.44 0.0002 6 216 
  Sex X Treatment 
X Age 
6.49 0.001 6 216 
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Table 2.5. Genes chosen for mRNA expression analysis in the MPN and VMN.  
Gene ID Gene name Tissue Predicted Targeting 
microRNA (# of 
binding sites) 
Igf1r Insulin-like growth factor 1 
receptor 
Female MPN 
 
mir-145 (2); mir-7 (3) 
 
Grin2a Glutamate receptor, ionotropic, N-
methyl-D-aspartate 2A 
Female MPN 
 
mir-7 (4); mir-145 (3) 
 
Ar Androgen receptor Male MPN 
Male VMN 
mir-124a (1) 
 
Pgr Progesterone receptor Male MPN 
 
mir-9 (2); let-7a (2); 
mir-124 (1)  
Ppara Peroxisome proliferator-activated 
receptor alpha 
Female VMN 
Male MPN 
 
mir-124a (2); mir-9 (1); 
let-7a (1); mir-219 (1) 
Lin28b Lin-28 homolog B Female VMN 
 
let7a (4) 
 
Clock Clock gene Female VMN 
Male VMN 
mir-124a (1) 
 
Lepr Leptin receptor Female VMN 
 
mir-219 (1) 
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Table 2.6. Statistical results of multiple comparisons ANOVA using age and treatment as 
independent variables for mRNA analysis in the MPN and VMN. Significant post-hocs for 
treatment when main effect of treatment or treatment X age interaction was significant are 
indicated in bold. 
mRNA Tissue Sex Main 
effect/Interaction 
F P Degree 
of 
freedom 
Residual 
degree of 
freedom 
Grin2a MPN Female Treatment 7.29 0.001 2 102 
   Age 13.26 0.001 3 102 
   Treatment X Age 3.96 0.001 6 102 
Igf1r MPN Female Treatment 7.21 0.001 2 102 
   Age 14.09 0.001 3 102 
   Treatment X Age 3.57 0.002 6 102 
Ar MPN Male Treatment 2.40 0.09 2 105 
   Age 11.50 0.001 3 105 
   Treatment X Age 4.15 0.0008 6 105 
Pgr MPN Male Treatment 12.04 0.001 2 105 
   Age 9.88 0.001 3 105 
   Treatment X Age 4.15 0.0008 6 105 
Ppara MPN Male Treatment 8.56 0.0003 2 105 
   Age 31.18 0.001 3 105 
   Treatment X Age 6.11 0.001 6 105 
Clock VMN Female Treatment 7.80 0.0006 2 107 
   Age 17.87 0.001 3 107 
   Treatment X Age 7.56 0.001 6 107 
Lepr VMN Female Treatment 0.54 0.5 2 107 
   Age 354.81 0.001 3 107 
   Treatment X Age 5.36 0.001 6 107 
Lin28b VMN Female Treatment 1.14 0.3 2 107 
   Age 4.55 0.004 3 107 
   Treatment X Age 5.06 0.0001 6 107 
Ppara VMN Female Treatment 2.30 0.1 2 107 
   Age 27.08 0.001 3 107 
   Treatment X Age 5.11 0.0001 6 107 
Ar VMN Male Treatment 1.22 0.2 2 108 
   Age 183.22 0.001 3 108 
   Treatment X Age 4.86 0.0001 6 108 
Clock VMN Male Treatment 0.25 0.7 2 108 
   Age 10.42 0.001 3 108 
   Treatment X Age 2.82 0.01 6 108 
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Discussion  
In the current study we profiled the expression of eight microRNAs in the 
developing MPN and VMN of the hypothalamus, and determined effects of gestational 
exposures to PCBs on microRNA expression. We further related changes in microRNA 
expression to changes in target gene mRNA expression changes in the same animals. Our 
major findings were that many more of the selected microRNAs were sexually 
dimorphic, and affected by prenatal EDC treatment in the MPN than the VMN. 
Importantly, EDC-treated females showed up-regulation of microRNAs at P30, in the 
midst of pubertal development, whereas males were affected (down-regulated) at P90, in 
adulthood. Relatively few EDC effects were found on the mRNA targets of these 
microRNAs, the implications for which are discussed below. As a whole, the results add 
to knowledge about EDC effects on microRNA expression, and provide new information 
about sex differences and developmental change in the hypothalamus. 
 
MicroRNA expression in the MPN changes with postnatal development and is 
sexually dimorphic 
The most common finding of our study was a developmental increase in 
microRNA expression as animals progressed from the juvenile through the pubertal 
period and into adulthood. In the MPN, six microRNAs (mir-132, mir-219, mir-7, mir-
145, let-7a, and let-7b) exhibited this pattern. The lin28/let-7 family has previously been 
investigated in the preoptic area, for which the expression of let-7a, let-7b, mir-132, and 
mir-145 increased with postnatal development. Changes in their expression were 
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suggested to be involved in the mechanisms permitting or leading to puberty onset 
(Sangiao-Alvarellos et al., 2013), as Lin28 overexpression in mice resulted in delayed 
puberty and increased body size (Zhu et al., 2010). Another previous study showed that 
seven of the eight microRNAs of the let-7 family were highly expressed in hypothalamic 
arcuate and paraventricular nuclei of adult rats (Amar et al., 2012). Our finding that let-
7a, let-7b, mir-132 and mir-145 expression increase with age in the MPN is consistent 
with those reports (Sangiao-Alvarellos et al., 2013) and add greater regional specificity 
by our focus on the MPN, which is a small sub-region of the entire preoptic area.  
To our knowledge, this is the first report on developmental changes in mir-219 in 
the brain. Together with mir-132, mir-219 is thought to be involved in the regulation of 
the biological clock (Cheng et al., 2007), with recent reports implicating a role in early 
development (Hudish et al., 2013), oligodendrocyte differentiation (Dugas et al., 2010), 
and modulation of NMDA receptor-mediated effects (Kocerha et al., 2009). Interestingly, 
the mir-219 and mir-132 expression patterns were quite similar across development, and 
most of our bionetwork analyses showed a significant positive correlation between these 
two microRNAs. Furthermore, these two microRNAs also frequently correlated with 
serum estradiol levels, especially in males. A previous study comparing mir-219 and mir-
132 in the fetal, adult, and diseased hippocampus, showed similar expression profiles 
(Lukiw, 2007), and NMDAR activation downregulated mir-219 and mir-132 expression 
in the adult dentate gyrus in vivo (Wibrand et al., 2010). Therefore, we speculate that in 
the MPN, and possibly other regions, mir-132 and mir-219 are involved in a common 
signaling pathway.  
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A developmental decrease in mir-9 was observed for both sexes. It has been 
reported that mir-9 is involved in regulating neurogenesis and maturational events at 
earlier, fetal stages of brain development (Krichevsky et al., 2003; Kapsimali et al., 2007; 
Denli et al., 2009). For example, mir-9 expression was highest in the fetal hippocampus 
and much lower in adult tissue (Lukiw, 2007). Our results are consistent with that 
finding. 
Several microRNAs in the MPN had sexually dimorphic expression. Females had 
higher levels of expression of mir-219, mir-7, and mir-145 than males, an effect driven 
by differences at P30. Although we do not know what this may represent, females mature 
earlier than males and are farther along in pubertal development than males at this age. 
There were also sexual dimorphisms in expression of mir-9 and let-7b, with males having 
higher levels of expression than females at P45, an age when males have just begun to 
attain adult reproductive function and where serum testosterone concentrations are at 
their peak (Zanato et al., 1994). We suggest that changes in sexually dimorphic 
microRNAs may be involved in, or reflect, pubertal changes in the MPN, but further 
work is needed to get at causal relationships. 
 
MicroRNA expression in the MPN increased by A1221 and EB in P30 females, and 
decreased by A1221 in P90 males  
In the females, prenatal A1221 and EB treated rats had increased expression of 
mir-219, mir-132, mir-7, mir-145, let-7a, and mir-124a at P30. Similarities between 
A1221 and EB are consistent with A1221’s ability to act via estrogenic mechanisms 
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(Dickerson et al., 2007). Effects of estrogens on neural microRNA expression have 
primarily been investigated in adults (Rao et al., 2013). In the aging female brain, for 
example, estradiol treatment differentially altered microRNA levels in an age- and brain 
region-dependent manner (Rao et al., 2013). To our knowledge, there are no studies that 
examined the effect of prenatal estradiol on microRNA expression in hypothalamus; 
however adult exposure studies in zebrafish and rodents (Cohen et al., 2008; Rao et al., 
2013), in addition to in vitro reports on effects of estradiol on microRNA expression in 
breast cancer cell lines [reviewed in (Klinge, 2009)], underscore the sensitivity of 
microRNA expression to estradiol treatment.  
In the male MPN, expression of all eight microRNAs examined was decreased in 
prenatally treated A1221 males on P90, an effect not mimicked by EB. This suggests that 
the mechanism for this A1221 effect in males likely involves a pathway other than 
through estrogen receptors. A reason for the sex difference may be the already greater 
exposure of prenatal male than female brains to estradiol (Forest, 1975; Roselli et al., 
1985), such that the addition of low-levels of exogenous EB had little influence in males 
compared to females. A1221 is weakly estrogenic but also has been shown to be anti-
androgenic at low doses (Bonefeld-Jorgensen et al., 2001; Portigal et al., 2002) and the 
decrease in microRNA expression observed in A1221 males may be caused by an 
antagonistic effect on the androgen receptor. 
The finding that prenatal EDC treatment effects are manifested at only a subset of 
developmental ages is consistent with our previously published study on these same rats, 
in which we measured mRNA expression in the anteroventral periventricular nucleus 
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(AVPV) and arcuate nucleus (ARC) (Walker et al., 2014). Results from that study 
showed individual postnatal gene expression profiles that were often affected at one or 
two ages, but not all ages, in prenatally exposed individuals. In other words, the age of 
analysis of EDC effects is critically important in determining the outcome. This is not 
surprising, as the profiles of different genes and proteins in the brain undergo dynamic 
change throughout postnatal development and may continue to change through aging 
(Kermath et al., 2014). 
 
MicroRNA expression in the VMN changes with postnatal development but have 
few sex differences or EDC effects  
In the VMN, all of the microRNAs studied increased their expression with age in 
both sexes. Our results for mir-132, mir-7, mir-145, let-7a, and let-7b are consistent with 
recent studies on microRNA expression in the medial basal hypothalamus (Sangiao-
Alvarellos et al., 2013). Mir-9, on the contrary, decreased during postnatal development 
in the medial basal hypothalamus (MBH) (Sangiao-Alvarellos et al., 2013), a result that 
may be explained by our VMN punch being a small sub-region within the entire MBH in 
which gene expression levels differ from those in neighboring regions.  
There were relatively few sex differences or effects of EDCs on microRNA 
expression in the VMN. In the females, there were modest changes in let-7a, mir-124a, 
and mir-219 in response to the EDCs that were developmental age-specific. In the male 
VMN, similarly to the male MPN, A1221 decreased the expression of mir-124a. To our 
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knowledge, there are no other EDC studies examining microRNA expression in the 
VMN.  
 
mRNA expression of targets of selected microRNAs 
We examined the expression levels of mRNAs that were selected based on the 
microRNA results. In the MPN, few EDC effects were found, but there were several 
changes with age. In the female MPN, Igf1r and Grin2a decreased expression with 
advancing developmental age. Consistent with that result, we reported that Igf1r mRNA 
decreased postnatally from P1 through P60 in the whole preoptic area (POA) of 
developing male and female rats (Walker et al., 2012). However that same study showed 
a small developmental age-related increase in Grin2a, with disparate results from the 
current study presumably due to differences in the dissection size from the previous 
(whole POA) and current (MPN) work. In our males, expression of Ar, Pgr, and Ppara 
decreased across development. These results were surprising, as the expression of Ar in 
the MPN was reported to increase with age in male hamsters during puberty (Meek et al., 
1997), and in our earlier rat studies, Ar as well as Pgr expression underwent significant 
postnatal developmental increases in the whole POA (Walker et al., 2009; Walker et al., 
2012). We are unaware of any reports on Ppara expression in the developing MPN. 
Results in the VMN also indicated few gene expression changes, but there were 
several age effects. In females, an age-related increase in expression of Lepr, Ppara, and 
Clock was detected. These genes have not been previously examined in the postnatal 
developing VMN, to our knowledge. In the male VMN, Ar increased with age, consistent 
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with other work in whole MBH (Walker et al., 2012), and Clock expression decreased 
with age. As the only mRNA measured in the VMN of both sexes, Clock expression had 
opposite developmental patterns (increase in females, decrease in males).  
Interestingly, for all of the mRNA results in both regions, we did not see a 
predicted inverse relationship with the microRNA expression. In fact, our network 
analysis revealed only positive correlations among mRNAs, microRNAs, and hormones. 
The lack of such a finding is attributable to a number of possibilities. First, we were only 
able to measure a small number of microRNAs and their mRNA targets. Other 
microRNAs not measured, and their combinations, may have a stronger association with 
mRNAs, and vice versa. Second, there are other molecular mechanisms for the regulation 
of gene expression that include DNA methylation, histone modifications, transcription 
factors, and post-transcriptional processes, that were not explored in the current study, 
but which contribute to the absolute expression of any gene. Finally, we have not looked 
at protein expression, thus changes in microRNA expression might affect protein 
translation.  
 
Conclusions and implications 
Several global conclusions can be drawn for the microRNAs and mRNAs 
measured herein. First, while both the MPN and VMN are sexually dimorphic in 
expression of various genes and proteins (Herbison et al., 1995; Cao et al., 2011), of the 
microRNAs measured here, expression was sexually dimorphic in the MPN, but not the 
VMN. Second, the PCB mixture A1221 affected microRNA expression in the MPN, and 
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to a lesser degree, in the VMN, in a region-, sex-, and age-specific manner. This finding 
indicates the importance of analyzing endpoints in both sexes and at multiple ages during 
postnatal development. Third, few treatment changes in the target mRNA expression 
were found, suggesting that mechanisms of action other than the selected subset of 
microRNAs are involved in regulation of their overall expression levels. Sex differences 
in microRNA expression have become an area of investigation for sex-biased 
neurobiological diseases such as autism, schizophrenia, and stroke (Guan et al., 2014; 
Mundalil Vasu et al., 2014; Selvamani et al., 2014). Furthermore, an increase in EDC 
exposures has been linked to playing a role in the rise in these multifactorial disorders 
(Brown, 2009; Melzer et al., 2012; Kalkbrenner et al., 2014). While it is premature to 
draw any strong inferences from these correlations, further research on connections 
among EDCs, microRNAs, and neurobehavioral outcomes is warranted.  
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Chapter 3: Sexually dimorphic effects of gestational endocrine-
disrupting chemicals on adult behaviors and mRNA expression 
 
Abstract 
Prenatal endocrine-disrupting chemicals [EDCs] exposures during critical periods 
of development may influence reproductive behaviors and the underlying neural 
architecture later in adulthood. This study examined effects of low-level gestational 
exposures to environmental EDCs on adult sociosexual behaviors, numbers and spectral 
characteristics of ultrasonic vocalizations [USVs], and gene expression changes in two 
hypothalamic nuclei. Pregnant Sprague-Dawley rats were injected on gestational days 16 
and 18 with vehicle [DMSO], estradiol benzoate [EB, 50 ug/kg], or a weakly estrogenic 
mixture of polychlorinated biphenyls [A1221, 1 mg/kg or 0.5 mg/kg]. Littermates were 
behaviorally characterized on P60. After the behavioral testing was completed, the 
animals were euthanized on P90. The medial preoptic nucleus [MPN] and ventromedial 
nucleus [VMN] of the hypothalamus, selected for their roles in reproductive function and 
behaviors, were microdissected and assayed for expression of 48 hypothalamic genes. 
The number and bandwidth of ultrasonic vocalizations were sexually dimorphic and 
sensitive to prenatal 0.5mg/kg A1221 treatment. Principle component analysis identified 
five sexually dimorphic USV measures that comprised the feminization score, and was 
used to accurately predict sex effects in the USV experiment. Females, but not males, 
showed the sociosexual preference for hormone-primed opposite-sex conspecific. 
Treatment with EB, 0.5mg/kg A1221 or 1mg/kg A1221 decreased nose-touching in 
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males [salient measure of direct social contact]. In the MPN, steroid hormone receptors 
and Kiss1 gene expression was increased in 0.5mg/kg A1221 females, while in the VMN, 
PCB effects were sex- and treatment-specific on a subset of neuroendocrine genes [Lepr, 
Foxp2, Esr1, Drd1a, Avpr1a, Crh, Oxt]. Bionetwork analysis showed the 0.5mg/kg 
A1221 group as the most different from DMSO, and, when examined for USV-associated 
behavioral measures, showed a robust increase in the number of correlations and network 
complexity. In summary, adult behaviors and selected hypothalamic genes were affected 
by prenatal EDCs, with 0.5mg/kg A1221 groups showing the most changes.  
 
Introduction 
Heightened sensitivity to circulating gonadal hormones during late gestation 
could sculpt the developing brain into male- or female-typical patterns. Exposure to 
environmental endocrine-disrupting chemicals [EDCs] during this period can change the 
neuroendocrine substrates and result in impaired metabolic, reproductive, neurochemical, 
and hormonal function in adulthood (Steinberg et al., 2007; Dickerson et al., 2011a; 
Dickerson et al., 2011b; Walker et al., 2013; Leon-Olea et al., 2014; Walker et al., 2014). 
A discernable consequence of endocrine disruption of the developing brain is the 
perturbation of adult behaviors. Published data on many EDCs, including polychlorinated 
biphenyls (PCBs), bisphenol A (BPA), and vinclozolin, show effects on social and 
sociosexual behavior in a sex and treatment-specific manner (Colbert et al., 2005; Ogi et 
al., 2013; Reilly et al., under review). Exposure to the single PCB congener 77 
diminishes partner preference in female rats for a male over a female stimulus animal 
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(Cummings et al., 2005). Aroclor 1221 (A1221), a more complex mixture of lightly 
chlorinated PCBs used in the current study, disrupts paced mating behavior in female rats 
(Steinberg et al., 2007) and same-sex social interactions in male rats (Reilly et al., under 
review). BPA exposures in mice decrease social motivational behavior in group setting in 
females, but increase it in males (Ogi et al., 2013), resulting in decreased preference to 
mate with exposed males (Jasarevic et al., 2011), and masculinized play behaviors in 
treated females (Dessi-Fulgheri et al., 2002). Prenatal treatment with anti-androgen 
vinclozolin increases play behaviors, but reduces copulatory behaviors in male rats 
(Colbert et al., 2005). Interestingly, environmentally low doses of 17alpha-ethinylestadiol 
also disrupt appetitive components of sexual behavior that influence the rate of 
copulation (Della Seta et al. 2008).  
We hypothesized that low doses of estrogenic A1221 would similarly disrupt 
affiliative components of opposite-sex interactions. The first test examined the number 
and quality of ultrasonic vocalizations produced after a period of interaction with the 
opposite-sex animal. A second behavioral test investigated sociosexual preference 
behaviors, namely whether the rats preferred to spend time with a hormone-implanted 
opposite-sex rat or a hormone-deprived opposite-sex animal. Finally, we measured 
hypothalamic gene expression in two sexually-dimorphic, hormone-sensitive 
hypothalamic nuclei, medial preoptic nucleus (MPN) and ventromedial nucleus (VMN), 
known to be involved in neuroendocrine control of social and sociosexual behaviors 
(Mathews et al., 1977; Clark et al., 1981; Malsbury et al., 1977; Hull et al., 2006; 
Hoshina et al., 1994, Kato et al., 2000).  
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Materials and methods 
Experimental animals  
All animal protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at University of Texas at Austin, permit number 201003712. Virgin 
female (n=40) and male Sprague-Dawley rats (n=15), two-three months of age, were 
purchased from Harlan Laboratories (Houston, TX). On arrival, animals were housed in 
same-sex groups, 2-3 animals per cage and provided low phytoestrogen Harlan-Teklad 
Extruded 2019 Global Rodent diet and water ad libidum. Animals were acclimated to 
housing conditions: temperature (21 – 22 ° C) with a partially reversed 12:12 light cycle 
(lights on at 12:00 AM). After two weeks of regular estrous cycles, the female rats were 
impregnated by the males from the same cohort.  
In the ultrasonic vocalizations experiment, the stimulus rat for male subjects was 
an ovariectomized [OVX] + E2 female of confirmed receptivity. The stimulus rat for 
female subjects was a sexually experienced intact male [age-matched unrelated sire]. 
Two novel gonadectomized opposite-sex animals (one hormone-implanted [E2-females; 
T-males] and one without hormone) were used as stimulus animals in the sociosexual 
preference experiment. 
 
Treatments 
On embryonic days 16 and 18 (E1 = day of confirmed sperm presence in vaginal 
smear), dams were weighed and randomly assigned to one of four treatment groups and 
injected intraperitoneally with 0.1 ml of vehicle (3% dimethylsulfoxide [DMSO], catalog 
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no. D4540; Sigma-Aldrich, St. Louis, MO; diluted in sesame oil, catalog no.156621, MP 
Biomedicals, Carlsbad, CA), 50µg/kg estradiol benzoate [EB] (catalog no. E8515; 
Sigma-Aldrich) as a positive estrogenic control, 0.5 mg/kg A1221 or 1 mg/kg A1221 
(catalog no. C-221N, AccuStandard, New Haven, CT). The dosages are within the range 
of PCB body burdens found in humans (Mitchell et al., 2012). Previous work in the 
laboratory using these dosages has been shown to be non-toxic to dams nor cause fetal 
loss (Steinberg et al., 2007; Dickerson et al., 2011a; Dickerson et al., 2011b); Walker et 
al., 2013; Walker et al., 2014). On the day after birth (postnatal day [P] 1), litter 
composition was recorded and the litters culled to equal sex ratios of 4 males and 4 
females (8 pups) per litter. Pups were weaned at P21 and rehoused in same-sex dyads 
where they were monitored daily for signs of pubertal development: vaginal opening 
(VO) in females and preputial separation (PPS) in males (Steinberg et al., 2007; Walker 
et al., 2012). Following VO, daily vaginal smears were taken and cell cytology examined 
as a measure of estrous cyclicity in the females. 
 
Behavior testing 
Beginning at age P60, male and female littermates were tested in the ultrasonic 
vocalizations and sociosexual behavioral paradigms. Testing was conducted under dim 
red light, two - six hours after lights off, with experimental females tested on proestrus 
when confirmed sexually receptive. Due to the extensive behavioral testing and the large 
number of animals necessary for the study, the animals were tested in eight cohorts (of 10 
animals each) with treatments equally assigned to each cohort.  
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Ultrasonic vocalizations: Ultrasonic vocalizations experiment was a three-day 
test in a sound-attenuated Plexiglas apparatus with a chamber (23l X 29w X 40h cm) 
divided by a wire mesh, and a microphone (CM16/CMPA, Avisoft, Germany). Days 1 
and 2, the experimental rat was placed into the apparatus, and USVs recorded for 10 
minutes to establish a baseline. Day 3, the rat was returned to the chamber and an 
unfamiliar opposite-sex stimulus animal placed on the other side of the wire mesh. After 
five minutes, the stimulus animal was removed and USVs recorded from the 
experimental animal for 10 minutes (McGinnis et al., 2003). USVs were recorded with 
UltraSoundGate hardware and software and analyzed with Saslab Pro (all Avisoft). 
Recordings were played at 512 FFT-length and 75% overlap while whistle tracking 
element separation, optimized to testing conditions, was used to automatically detect and 
characterize calls. Number of flat and frequency-modulated 50kHz USVs were quantified 
for Days 1-3. Power spectrum measures (dominant frequency, entropy, bandwidth, 
internode interval, and duration) were quantified for Day 3 only. Frequency-modulated 
USVs were further characterized by the type of modulation into rises, trills, and steps 
(Wright et al., 2010).  
Principle component analysis: We performed a principle component analysis on 
data from vehicle-treated males and females to identify the attributes of vocalizations that 
loaded strongly on sex. Using JMP 11 statistical software, we scored sex as a dummy 
variable (-1 = male, +1 = female), and analyzed all of our measures of Day 3 
vocalizations. These measures included numbers of vocalizations in each category of 
USV, as well as bandwidth, entropy, and duration measures in each category. After 
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varimax rotation of the PCA results, we identified a single factor that loaded highly on 
sex; we interpret this factor as a measure of feminization/masculinization. We used the 
factor loadings to create a composite score that could be used to investigate the effects of 
our treatments on the sex-typical patterns of vocalization.  
We calculated the feminization/masculinization PCA score for all animals (all 
treatments and sexes) by converting each of the variables that loaded highly onto sex into 
a Z-score, then weighting each of the variables by its loading onto the sex-specific factor 
identified in the PCA. For simplicity, we included only those variables with a factor 
loading of magnitude greater than 0.30. The formula for computing the composite score 
was: PCA score = 0.32 x number of flat calls Z score - 0.34 x duration of rises Z score + 
0.47 x duration of steps Z score + 0.46 x bandwidth of steps Z score + 0.42 x bandwidth 
of trills Z score.  To confirm that this score was sexually dimorphic, we first performed a 
one-way ANOVA for effects of sex on the score, as well as on its component variables. 
Lastly, we calculated a PCA score for all individuals in our study, and used a two-way 
ANOVA to calculate the effects of sex, treatment, and sex-by-treatment interactions.  
Sociosexual preference behavior: The sociosexual behavior test used a Stoelting 
Any-Maze three-chamber plexiglas apparatus (100l X 100w X 34.5h cm total size), with 
restraint cages containing the stimulus animals placed in opposite corners of the side 
chambers (Moy et al., 2004; Crews et al., 2012). The test took place immediately after 
USV testing on Day 3 was completed. The experimental animal was habituated in the 
center compartment for five minutes with the side chamber doors closed. After 
habituation, the doors were opened, and the experimental animal allowed to explore the 
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whole arena for 10 minutes. Any-Maze software quantified distance travelled, average 
speed, time standing still, and time spent near each stimulus animals. Other behaviors 
(time at plexiglas, time spent investigating stimulus animals enclosure, rearing, 
grooming, and nose touching) were manually scored by a trained observer blind to 
treatment.  
 
Tissue collection and storage 
Testing was completed by P90 and experimental animals were weighed and 
euthanized one – to - three hours before lights out via rapid decapitation. Trunk blood 
samples were collected, allowed to clot, and centrifuged to obtain serum samples. Brains 
were removed and cut into one mm sections; and one mm micropunches of MPN and 
VMN were collected using methods reported previously (Walker et al., 2013; Walker et 
al., 2014). Females exhibiting estrous cycles were euthanized on proestrus based on 
vaginal cytology. Tissues and organs were stored at -80°C until use.  
 
RNA isolation 
Total RNA was isolated from frozen MPN and VMN punches of behaviorally 
tested male and female rats using a mirVana miRNA isolation kit according to the 
manufacturer’s protocols (catalog no. AM1560, Life Technologies, Carlsbad, CA). All 
RNA samples were analyzed for quantity by Nanodrop spectrophotometry and run on 
Bioanalyzer 2100 nanodrop kit (catalog no. 5067-1511, Agilent Technologies, Santa 
Clara, CA) to assess RNA purity and integrity. Only RNA samples with the RIN of eight 
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or higher were used in subsequent experiments. Based on this criterion, five samples 
were excluded from the analysis in the MPN, and eight were excluded from the analysis 
in the VMN, resulting in a sample size of eight – to – ten animals per group.  No animals 
failed this criterion for both regions.  
 
cDNA synthesis and Taqman microfluidic real-time PCR cards  
Total RNA (200 ng total) was used to generate cDNA using high-capacity cDNA 
reverse transcription kit with RNase inhibitor (catalog no. 4374966, all Life 
Technologies) according to the manufacturer’s recommended protocols. For Taqman Loq 
Density Array (TLDA) analysis, custom-designed microfluidic 48-gene PCR cards (Life 
technologies) were used to analyze the chosen mRNAs. Real-time PCR was carried out 
on an ABI ViiA7 using Taqman universal master mix (catalog no. 4324018, Life 
Technologies) and the following run parameters: 95 °C for 10 minutes, 50 cycles of 95 
°C for 15 seconds, and 60°C for 1 minute. Relative expression was determined for each 
sample using the comparative cycle threshold (Ct) method (Pfaffl, 2001). The Cts were 
further calibrated to the median δ-cycle threshold of the DMSO females to determine the 
relative Ct value for each mRNA. 
  
Statistics  
All statistical analyses were conducted using R software. Initial statistical 
analyses using Analysis of variance (Terranova et al., 1993) were used to identify any 
potential cohort, litter, and sex effects within groups. ANOVA tests were also used to 
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compare the treatment groups. All data were normally distributed and homoscedastic. 
When appropriate, a repeated measures multiple comparisons MANOVA (which 
addresses the false discovery rate of multiple comparisons) was used to analyze 
behavioral measures between the lateral chambers in the Anymaze apparatus and the 
numbers of ultrasonic vocalizations on three days of USV experiment. Grubb’s test was 
used to exclude up to 2 outliers per group in the dataset.  Posthoc analyses included t-test 
for sex effect and Tukey HSD for treatment and interaction effects. All data are presented 
at mean ± standard error of the mean. Because genes and behavioral measures were 
specifically chosen based on an a priori hypothesis, we report statistical significance as P 
< 0.05 and trends as P < 0.1.  
 
Bionetwork analysis 
To examine possible relationships among behaviors, genes, and serum 
corticosterone levels (hormone data published in Reilly et al., under review), the data 
were analyzed using a bootstrap technique, as previously reported (Walker et al., 2013; 
Walker et al., 2014). The TLDA data for MPN and VMN were used to generate the 
networks for each region. The following behavioral data were affected by treatment and 
selected for network generation: USV numbers and bandwidth on Day 3, time spent near 
each stimulus animal, stimulus animal enclosure exploration, and nose touching. The 
sociosexual measures were presented as ratio of GDX+hormone measure divided by sum 
of GDX+hormone and GDX measures.  
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Results  
There were no effects of litter or cohort on any of the behavioral or gene 
expression measures examined.   
Ultrasonic vocalizations (USV): Females vocalized higher numbers of USVs 
than males: numbers of flat (F1, 476  = 18.7, p < 0.001), rise (F1, 480  = 4.7, p < 0.05), and 
step (F1, 477  = 10.5, p<0.005) USVs, but not trill USVs, were significant for the main 
effect of sex. Number of calls increased across the three-day trial and were significantly 
higher for all call categories on Day 3 compared to Days 1 or 2 (females: flats: F2, 148  = 
39.2; rises: F2, 152  = 37.5; steps: F2, 151  = 52.7; trills: F2, 148  = 34.2; males: flats: day, F2, 
144  = 107.7; rises: F2, 145  = 85.5; steps: F2, 149  = 99.6; trills: F2, 147  = 58.2, all p < 0.001).  
A main effect of prenatal treatment was found, with the 0.5 mg/kg A1221 groups having 
increased numbers of rise calls in females (F3, 79  = 5.6, p < 0.005) and males (F3, 71  = 9.4, 
p < 0.0005) compared to their DMSO counterparts. In males, the 0.5 mg/kg A1221 group 
also had increased numbers of step calls (F3, 75  = 8.0, p < 0.001). Furthermore, the 
treatment x day interaction was significant with the increase in the numbers of USVs 
produced by 0.5 mg/kg A1221-treated rats observed on day 3 only for numbers of rises 
(F6, 152  = 2.8), steps (F6, 151  = 2.8, both p < 0.05) and trills (F6, 148  = 3.88, p < 0.005) in 
females and numbers of rises (F6, 145  = 4.95) and steps (F6, 149  = 5.05, both p < 0.0005) in 
the males (Figure 3.1A-H).  
Power spectrum analysis revealed bandwidth of the flat, rise, step, and trill 
USVs significant for the main effect of sex (flats, F1, 78  = 5.5; rises, F1, 72  = 5.0, both p < 
0.05; steps, F1, 75  = 12.2; trills, F1, 70  = 12.9, both p < 0.001) where the females produced 
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calls with higher bandwidth compared to males. The entropy was also significant for the 
main effect of sex, with the females producing calls with higher entropy than males in 
rise (F 1, 74  = 8.7, p < 0.005), step (F1, 72 = 5.7, p < 0.05), and trill (F1, 73  = 7.1, p < 0.01), 
but not flat USVs. Main effect of prenatal EB and 1 mg/kg A1221 treatment increased 
bandwidth of male calls with EB increasing it for rise calls (F3, 34  = 3.9, p < 0.05), and 1 
mg/kg A1221 increasing it for trill calls (F3, 31  = 4.5, p < 0.01) (Figure 3.2A-H). There 
were no sex effects for duration, internode interval, and dominant frequency. In males, 
main effect of prenatal treatment with 0.5 mg/kg A1221 increased duration of flat calls 
(F3, 35  = 3.2, p < 0.05) (Figure 3.3A-L).   
Principle component analysis (PCA) of acoustic properties and USV 
numbers: There were 16 components total in the PCA analysis of acoustic properties and 
USV numbers. Sex loaded onto components 1 (score = 0.49) and 7 (score = 0.46) most 
strongly. To clarify the interpretation of factors, we performed a varimax rotation of the 
PCA analysis. After rotation, the factor loadings for 1 and 7 were (0.35) and (0.74), 
respectively. Because factor 7 loaded most strongly on sex, we interpret it as a measure 
of feminization/masculinization in USV. We identified five measures in factor 7 with a 
factor loading of magnitude > 0.30: trill bandwidth (0.42), step bandwidth (0.46), step 
duration (0.47), rise duration (-0.34), and numbers of flat USVs (0.32). These measures 
were analyzed in DMSO animals for the effects of sex. Consistent with the signs of their 
factor loadings, four measures (trill bandwidth, step bandwidth, step duration, and 
numbers of flat calls) were higher in DMSO females than DMSO males, while duration 
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of rise calls was higher in DMSO males than DMSO females (all, p < 0.01) (Figure 
3.4A-D).  
A PCA score based on our factor loadings was calculated for all animals as 
described in the methods, and then analyzed by two-way ANOVA for effects of sex, 
treatment, and their interactions. We found a main effect of sex (F1, 19 = 14.28, p < 0.01), 
but no treatment or treatment x sex interactions (Figure 3.4E).     
Sociosexual preference behavior: The main effect of sex was significant in 
several sociosexual behavior measures. Females, but not males, spent more time near the 
hormone primed stimulus animal (F1, 65  = 19.1, p < 0.0005), investigating its enclosure 
(F1, 64  = 13.7, p < 0.0005), and nose-touching with it (F1, 63  = 8.5, p < 0.005) compared to 
the castrated animal. Males took longer time to start investigating the stimulus animal 
enclosure (F1, 228  = 19.8, p < 0.0005). Additionally, the main effect of treatment was 
significant for males treated with prenatal PCBs (1 mg/kg or 0.5 mg/kg A1221) or EB 
who spent less time nose-touching with stimulus animals, irrespective of the stimulus 
animal hormone status (F3, 61  = 7.6, p < 0.0005) (Figure 3.5A-D). Distance travelled (F1, 
132  = 89.7, p < 0.0005), average speed (F1, 132  = 90.2, p < 0.0005), and time at plexiglas 
(F1, 132  = 44.0, p < 0.0005) were significant for the main effect of sex with females 
engaging more time in these activities than males. Compared to females, males spent 
more time standing still (F1, 129  = 35.2, p < 0.0005) and grooming (F1, 127  = 9.3, p < 
0.005). Main effect of treatment was significant for the 1 mg/kg A1221 males who spent 
less time rearing than DMSO males (F3, 60  = 3.2, p < 0.05) (Figure 3.6A-F).  
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Medial preoptic nucleus TLDA results: In females, main effect of prenatal 
treatment with 0.5 mg/kg A1221 increased the expression of Ar (F3, 35  = 6.7, p < 0.05), 
Esr1 (F3, 36  = 7.4, p < 0.001), Esr2 (F3, 35  = 5.6, p < 0.005), and Kiss1 (F3, 29  = 6.6, p < 
0.005). Ar expression was also increased by prenatal 1 mg/kg A1221 treatment in females 
(F3, 35  = 6.7, p < 0.05). There were no treatment effects in the males compared to the 
DMSO. Esr1 (F1, 73  = 4.4, p < 0.05) was significant for the main effect of sex in the MPN 
with higher levels of expression in the females compared to the males (Figure 3.7A-D). 
The following genes were also significant for the main effect of sex in the MPN, and had 
higher levels of expression in females compared to males: Drd2 (F1, 72  = 4.9, p < 0.05), 
Crh (F1, 71  = 15.2, p < 0.0005), Egr1 (F1, 68  = 24.6, p < 0.0005), Igf1 (F1, 72  = 7.0, p < 
0.01), Igr1r (F1, 70  = 4.7, p < 0.05), and Per1 (F1, 71  = 6.9, p < 0.05). The genes Slc6a3 
(F1, 64  = 7.7, p < 0.01) and Oprd1 (F1, 69  = 10.0, p < 0.005) showed main effect of sex 
with higher levels of expression in males compared to females (Figure 3.8A-H).  
Ventromedial nucleus TLDA results: In females, the main effect of prenatal EB 
treatment increased expression of Esr1 (F3, 34  = 3.9, p < 0.05), while 0.5 mg/kg A1221 
decreased expression of Drd1a (F3, 37  = 4.9, p < 0.01), and 1 mg/kg A1221 increased 
expression of Avpr1a (F3, 38  = 3.6, p < 0.05). In males, the main effect of prenatal EB and 
0.5 mg/kg A1221 increased expression of Crh (F3, 32  = 3.8, p < 0.05), while 0.5 mg/kg 
A1221 increased the expression of Foxp2 (F3, 36  = 3.3, p < 0.05) and Lepr (F3, 36  = 4.9, p 
< 0.01); 1 mg/kg A1221 increased the expression of Oxt (F3, 34  = 4.1, p < 0.05). Esr1 
expression was significant for the main effect of sex in the VMN with higher levels of 
expression in the females compared to the males (Figure 3.9A-G). The following genes 
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were also significant for the main effect of sex in the VMN with higher levels of 
expression in females compared to males: Pgr (F1, 80  = 13.6, p < 0.0005), Drd3 (F1, 78  = 
8.1, p < 0.01), Oprk1 (F1, 78  = 11.7, p < 0.005), and Per2 (F1, 80  = 8.9, p < 0.005). The 
genes Grin2a (F1, 80  = 11.0, p < 0.005), Foxp2 (F1, 78  = 11.4, p < 0.005), Rapgef4 (F1, 80  = 
4.3, p < 0.05), and Shank1 (F1, 80  = 6.0, p < 0.05) were significant for the main effect of 
sex with higher levels of expression in males compared to females (Figure 3.10A-H).  
Bionetwork analysis: Bionetwork analysis was conducted using Pearson 
correlation coefficients to enable investigation into relationships among behaviors, 
hormones, and gene expression in the MPN. In the female MPN (Figure 3.11), all 
networks showed more positive than negative correlations, however the complexity of the 
networks (qualitative visual measure of network organization) and the identity of the 
correlated measures in DMSO and treated networks differed. Relative to DMSO, EB 
treatment resulted in visually more complex and organized networks with higher number 
of correlations, and 1mg/kg A1221 resulted in less organized networks, while 0.5mg/kg 
A1221 did not differ visually. Additionally, female EB networks showed a greater 
number of positive correlations between genes than DMSO and PCB-treated females.  
The effects of treatment on the identity of correlated measures were examined by 
comparing the correlations formed by bandwidth of rise calls. Bandwidth of flat, rise, 
step and trill USVs correlated with several interesting measures in the female MPN. 
While there are too many bandwidth correlations to discuss here, we will provide a 
detailed description of correlations formed by bandwidth of rise calls. In DMSO females, 
bandwidth of rise calls formed positive correlations with Avpr1a, Ar, Foxp2 gene 
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expression, in addition to positive correlations with the numbers of rise and step USVs, 
and negatively correlated with Avp and Oxt gene expression. In EB females, bandwidth 
of rise calls formed positive correalations with Oprd1, Esr2, Shank1, and negatively 
correlated with Lepr, Oxtr, and Oprk1. In 0.5mg/kg A1221 females, bandwidth of rise 
calls formed positive correlations with gene expression of the following genes in the 
MPN: Rapgef4, Oprd1, Oprl1, Fmr1, Grin2b, Grin1, Kiss1, Oxt, Oxtr, Crh, Ar, Nlgn3, 
Clock, Per2, Nr3c1, Slc6a3, Foxp1, and negatively correlated with Drd1a, Bdnf, and Th 
gene expression. In 1mg/kg A1221 females, bandwidth of rise calls formed one positive 
correlation with Th gene expression (Figure 3.11A-D).  
In the male MPN (Figure 3.12), 0.5mg/kg A1221 treatment, but not EB or 
1mg/kg A1221, affected network complexity and resulted in a more organized network 
with higher number of correlations, compared to DMSO. Despite this differential effect 
on network organization, all treatments affected the identity of correlated relationships.  
We will compare the effects of treatment on identity of correlated measures by 
comparing the correlations formed by bandwidth of rise calls. In DMSO males bandwidth 
of rise calls did not form any correlations. In EB males, bandwidth of rise calls formed 
positive correlations with Bdnf, Gper, Lepr, and Drd1a, and a negative correlation with 
Grin2b. In 0.5mg/kg A1221 males, bandwidth of rise calls formed positive correlations 
with bandwidth of flat calls and gene expression of Drd1a and negative correlations with 
Oprd1, Oprl1, Lepr, Drd2, Kiss1r, Clock, Per1, Nlgn3, Fmr1, and Nr3c1. In 1mg/kg 
A1221 males, bandwidth of rise calls formed a positive correlation with Igf1r and a 
negative correlation with Ar gene expression.  
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Bionetworks were also used to analyze the relationships among behaviors, 
hormones, and gene expression in the VMN. In the female VMN (Figure 3.13), the 
complexity of the networks were as follows: EB > DMSO > 0.5mg/kg A1221 > 1mg/kg 
A1221, where EB treatment resulted in more complex networks, with higher number of 
correlations, and 0.5mg/kg A1221 and 1mg/kg A1221 networks having fewer number of 
correlations, all compared to DMSO.  In the female VMN, bandwidth of rise calls was 
differentially affected in treated networks compared to DMSO, and illustrates an example 
of EDC effects on gene-behavior-hormone relationships. In DMSO females, bandwidth 
of rise calls formed positive correlations with numbers of rise and step USVs, and Oprd1, 
and formed negative correlations with Oprk1, Dbh, Drd1a, Foxp1, Crh, Egr1, Nlgn3, 
Fmr1, Igf1r, Clock, and Shank 1.  In EB females, the bandwidth of rise calls formed 
positive correlations with Oxt, Drd1a, Pgr, Esr2, Igf1, and Grin2a, and formed negative 
correlation with Oprm1. In 0.5mg/kg A1221 or 1mg/kg A1221 females, bandwidth of 
rise calls did not form any correlations.  
In the male VMN (Figure 3.14), treatment with EB or 0.5mg/kg A1221 resulted 
in visually more complex networks compared to DMSO, while 1mg/kg A1221 networks 
did not differ from DMSO. However, identity of the correlated relationships was affected 
by PCB treatment and differed depending on the treatment. In DMSO males, bandwidth 
of rise calls did not form any correlations, while in EB males bandwidth of rise calls 
correlated positively with Pgr expression and negatively with Per1 gene expression. In 
0.5mg/kg A1221 males, bandwidth of rise calls formed positive correlations with Ar, 
Esr1, Kiss1, Lepr, Per2, Per1, Arntl, Drd1a, Pgr, Grin2b, and Grin1, and a negative 
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correlation with Foxp2. In 1mg/kg A1221 males, bandwidth of rise calls formed negative 
correlations with Esr2, Arntl, and Th.  
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Figures  
 
Figure 3.1: Number of flat, rise, step, and trill ultrasonic vocalizations (USVs) in females 
(A-D) and males (E-H). Significant main effects of day, sex, and treatment are shown. 
Significant post-hocs for treatment are indicated when the treatment x day interaction was 
significant as *p < 0.05 0.5 mg/kg A1221 vs. DMSO on same day. Abbreviations: A1221 
(0.5), 0.5 mg/kg A1221; A1221 (1.0), 1 mg/kg A1221. 
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Figure 3.2: Bandwidth (A-D) and entropy (E-H) of flat, rise, step, and trill ultrasonic 
vocalizations (USVs) on Day 3 in males and females. Significant main effects of sex are 
shown. Significant post-hocs for treatment are indicated when the main effect of 
treatment within each sex was significant as +p < 0.05 1 mg/kg A1221 vs. DMSO; #p < 
0.05 EB vs. DMSO. Abbreviations: A1221 (0.5), 0.5 mg/kg A1221; A1221 (1.0), 1 
mg/kg A1221.  
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Figure 3.3: Duration (A-D), internode interval (E-H), and dominant frequency (I-L) of 
flat, rise, step, and trill ultrasonic vocalizations (USVs) on Day 3 in males and females. 
Significant post-hocs for treatment are indicated when the main effect of treatment within 
each sex was significant as *p < 0.05 0.5 mg/kg A1221 vs. DMSO. Abbreviations: 
A1221 (0.5), 0.5 mg/kg A1221; A1221 (1.0), 1 mg/kg A1221.  
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Figure 3.4: Sexually dimorphic USV measures that comprise the feminization score: 
bandwidth of trills and steps, duration of steps, number of flats, and duration of rises (A-
E). Feminization score is shown in F. Significant main effect of sex is shown for F as p-
value. Significant effects of sex are shown for A-E as *p<0.05 DMSO female vs. DMSO 
male. Abbreviations: A1221 (0.5), 0.5 mg/kg A1221; A1221 (1.0), 1 mg/kg A1221.  
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Figure 3.5: Sociosexual preference behaviors: time spent near stimulus animals, 
exploring their enclosures, and nose-touching with them (A-C). Latency to first 
exploration of stimulus animal enclosure is also shown (D). Significant main effects of 
sex and hormone status in females are shown. Significant post-hocs for treatment are 
indicated when the main effect of treatment was significant within each sex as *<0.05 0.5 
mg/kg A1221 vs. DMSO; #p < 0.05 EB vs. DMSO. Abbreviations: A1221 (0.5), 0.5 
mg/kg A1221; A1221 (1.0), 1 mg/kg A1221; GDX male, gonadectomized male; GDX+T 
male, gonadectomized male with testosterone replacement; OVX female, ovariectomized 
female; OVX+E2 female, ovariectomized female with estradiol replacement.   
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Figure 3.6: Sociosexual preference behaviors: distance travelled, average speed, time 
standing still, grooming, rearing, and time at Plexiglas (A-F). Significant main effects of 
sex are shown. Significant post-hocs for treatment are indicated when the main effect of 
treatment within each sex was significant as +p < 0.05 1 mg/kg A1221 vs. DMSO. 
Abbreviations: A1221 (0.5), 0.5 mg/kg A1221; A1221 (1.0), 1 mg/kg A1221.  
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Figure 3.7: Gene expression of androgen receptor [Ar], estrogen receptor α [Esr1], 
estrogen receptor β [Esr2], and kisspeptin [Kiss1] in MPN (A-D). Significant main 
effects of sex are shown. Significant post-hocs for treatment are indicated when the main 
effect of treatment within each sex was significant as *p < 0.05 0.5 mg/kg A1221 vs. 
DMSO; +p < 0.05 1 mg/kg A1221 vs. DMSO. Abbreviations: A1221 (0.5), 0.5mg/kg 
A1221; A1221 (1.0), 1mg/kg A1221.  
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Figure 3.8: Gene expression of sexually dimorphic genes dopamine receptor D2 [Drd2], 
corticotropin releasing hormone [Crh], early growth response 1 [Egr1], insulin-like 
growth factor 1 [Igf1], insulin-like growth factor 1 receptor [Igf1r], period circadian clock 
1 [Per1], dopamine transporter [Slc6a3], δ-opioid receptor [Oprd1] (A-H) in the MPN. 
Significant main effects of sex are shown. Abbreviations: A1221 (0.5), 0.5 mg/kg A1221; 
A1221 (1.0), 1 mg/kg A1221.  
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Figure 3.9: Gene expression of estrogen receptor α [Esr1], dopamine receptor D1 
[Drd1a], arginine vasopressin receptor 1a [Avpr1a], forkhead box protein P2 [Foxp2], 
corticotropin releasing hormone  [Crh], leptin receptor [Lepr], and oxytocin [Oxt] in 
VMN (A-G). Significant main effects of sex are shown. Significant post-hocs for 
treatment are indicated when the main effect of treatment within each sex was significant 
as *p < 0.05 0.5 mg/kg A1221 vs. DMSO; +p < 0.05 1 mg/kg A1221 vs. DMSO; #p < 
0.05 EB vs. DMSO. Abbreviations: A1221 (0.5), 0.5mg/kg A1221; A1221 (1.0), 1mg/kg 
A1221. 
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Figure 3.10: Gene expression of sexually dimorphic genes progesterone receptor [Pgr], 
dopamine receptor D3 [Drd3], k-opioid receptor [Oprk1], period circadian clock 2 
[Per2], ionotropic glutamate receptor NMDA 2A [Grin2a], forkhead box protein P2 
[Foxp2], Rap guanine nucleotide exchange factor 4 [Rapgef4], SH3 and multiple ankyrin 
repeat domains protein 1(Shank1) (A-H) in the VMN. Significant main effects of sex are 
shown. Abbreviations: A1221 (0.5), 0.5 mg/kg A1221; A1221 (1.0), 1 mg/kg A1221.  
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Figure 3.11: Cytoscape analysis of behaviors, genes, and serum corticosterone in the 
female MPN (A-D). Abbreviations: nose touching, time spent nose-touching with 
hormone-primed rat; investigating enclosure, time spent investigating hormone-primed 
animal enclosure; time near rat, time spent near hormone-primed rat; flat, number of flat 
USVs; rise, number of rise USVs; step, number of step USVs; trill, number of trill USVs; 
flat BW, bandwidth of flat USVS; rise BW, bandwidth of rise USVs; step BW, 
bandwidth of step USVs; trill USV, bandwidth of trill USVs; cort, corticosterone.  
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Figure 3.12: Cytoscape analysis of behaviors, genes, and serum corticosterone in the 
male MPN (A-D). Abbreviations: nose touching, time spent nose-touching with 
hormone-primed rat; investigating enclosure, time spent investigating hormone-primed 
animal enclosure; time near rat, time spent near the hormone-primed rat; flat, number of 
flat USVs; rise, number of rise USVs; step, number of step USVs; trill, number of trill 
USVs; flat BW, bandwidth of flat USVS; rise BW, bandwidth of rise USVs; step BW, 
bandwidth of step USVs; trill USV, bandwidth of trill USVs; cort, corticosterone.  
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Figure 3.13: Cytoscape analysis of behaviors, genes, and serum corticosterone in the 
female VMN (A-D). Abbreviations: nose touching, time spent nose-touching with 
hormone-primed rat; investigating enclosure, time spent investigating hormone-primed 
animal enclosure; time near rat, time spent near hormone-primed rat; flat, number of flat 
USVs; rise, number of rise USVs; step, number of step USVs; trill, number of trill USVs; 
flat BW, bandwidth of flat USVS; rise BW, bandwidth of rise USVs; step BW, 
bandwidth of step USVs; trill USV, bandwidth of trill USVs; cort, corticosterone.  
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Figure 3.14: Cytoscape analysis of behaviors, genes, and serum corticosterone in the 
male VMN (A-D). Abbreviations: nose touching, time spent nose-touching with 
hormone-primed rat; investigating enclosure, time spent investigating hormone-primed 
animal enclosure; time near rat, time spent near the hormone-primed rat; flat, number of 
flat USVs; rise, number of rise USVs; step, number of step USVs; trill, number of trill 
USVs; flat BW, bandwidth of flat USVS; rise BW, bandwidth of rise USVs; step BW, 
bandwidth of step USVs; trill USV, bandwidth of trill USVs; cort, corticosterone.  
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Discussion  
This study was first to report the effects of sex and prenatal PCB disruption on 
ultrasonic vocalizations in rats. A principle component analysis was used to identify 
sexually dimorphic USV measures. Additionally, sociosexual preference behaviors were 
analyzed in the same animals. The changes in neuroendocrine gene expression were 
examined in the behaviorally tested animals for sexual dimorphisms and effects of PCB 
exposures. Finally, a bionetwork analysis was conducted on behavioral and molecular 
endpoints to examine the PCB effects on gene-behavior-hormone relationships.   
 
Ultrasonic vocalizations were sexually dimorphic and sensitive to prenatal PCB 
disruption  
We found that numbers of flat, rise, and step, but not trill USVs were significant 
for the main effect of sex, with females having higher numbers of USVs than males. We 
also found that both males and females vocalized higher number of USVs after 
interaction with an opposite-sex animal. This finding was expected since presence of an 
opposite-sex conspecific is a known salient cue (Andersson, 1994), and salient cues are 
known to elicit higher numbers of vocalizations (Ma et al., 2014; Brown et al., 1988). 
Previous studies show that exposure of adult rats to novel (i.e. salient) social cues evoked 
differential increases in USVs across sex, with males exhibiting a much more robust 
increase in USV production both with respect to the frequency and complexity of USV 
production (Ma et al., 2014). Exposure to an estrous female in particular causes an 
 88 
extraordinary increase in USVs in male subjects (Ma et al., 2014). Others have reported 
that presence of a partner’s odor is sufficient to increase the number of vocalizations 
(Brown et al., 1988). We find that prenatal treatment with 0.5mg/kg A1221 increased the 
number of rise calls in both males and females, and number of step calls in males. The 
increase in the numbers of USVs produced by 0.5 mg/kg A1221-treated rats was 
observed on Day 3 only for the number of rises, steps and trills in females and the 
number of rises and steps in the males. We speculate that since treatment preferentially 
affected the frequency-modulated calls, they might be programmed prenatally and, as a 
result, be more sensitive to hormonal perturbation by EDCs. This is the first report 
examining the effects of endocrine disruption on numbers of USVs; no comparisons to 
previous literature can be made.  Other studies have investigated the effect of sex 
hormone (estradiol and testosterone), mediating a clear dependence of USV production 
on intact hormonal system (reviewed in Yamaguchi et al., 2002), with loss of 
vocalizations in castrated animals with its restoration to pre-gonadectomy levels with 
testosterone replacement (Ball et al., 2004; Bass et al., 2008).  
 
Bandwidth of calls was sexually dimorphic and sensitive to disruption with prenatal 
PCBs 
Power spectrum analysis revealed that bandwidth and entropy of rises, steps, and 
trills were higher for females compared to males. Bandwidth, but not entropy, was higher 
for female flats compared to male flat USVs. Bandwidth and entropy are related power 
spectrum measures and similarly measure how energy is dispersed over frequency of the 
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call (Fernandez-Vargas et al., 2015). We suggest that changes in bandwidth and entropy 
may underlie motivational-structural differences between sexes in USV production. Two 
conclusions can be made from these results: first, females are more motivated to vocalize 
(thus the higher bandwidth and entropy of the calls); second, males have more capacity to 
vocalize (thus the higher bandwidth and entropy are not needed for USV production). We 
are unable to exclude either, and both could be contributing to the sex differences in 
bandwidth and entropy. Previous studies have examined bandwidth and entropy in 
rodents, and show higher entropy and bandwidth in female golden hamster calls 
(Fernandez-Vargas et al., 2015), and minor sex differences in acoustic characteristics in 
mouse calls (Hammersmidt et al., 2012). Prenatal EB and 1mg/kg A1221 treatment 
increased bandwidth of male rise and trill calls, respectively. This finding was interesting 
since prenatal treatment increased the bandwidth of male calls, possibly leading to 
female-like bandwidth levels in treated males. Bandwidth has not been previously shown 
to be affected by PCB treatment, thus we report it for the first time herein.  
 
Principle component analysis (PCA) identified sexually dimorphic USV measures 
Principle component analysis for USV power spectrum and numbers data 
indicated a score that strongly predicted sex differences. The PCA score was composed 
of five vocalization measures (trill bandwidth, step bandwidth, duration of rise and step 
USVs, and numbers of flat USVs). Four of the five measures were found to be higher in 
DMSO females than DMSO males, while duration of rise calls were found to be higher in 
DMSO males relative to DMSO females. When we examined the effects of sex and 
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treatment across all animals (all treatments and sexes), we found significant sex effects, 
but no treatment or treatment X sex interactions. The significant sex effects confirmed the 
usefulness of a score as a predictor for sex differences in USV outcomes. We interpreted 
absence of treatment effects or treatment by sex interactions as a lack of feminizing or 
masculinizing effects of EDC treatment on the USV outcomes. No such analysis has been 
previously conducted, thus we are unable to make any previous comparisons to the 
literature. We suggest that five vocalization measures that comprise the PCA score may 
underlie the sexually dimorphic nature of USVs in our experimental setup.  
 
Males, but not females, lack preference for hormone-primed conspecific, and are 
more sensitive to PCB disruption  
Females, but not males, spent more time near the gonadectomized, hormone-
treated stimulus animal, investigating its enclosure, and nose-touching with it compared 
to the gonadectomized animal. This suggests that females, but not males, preferred to 
interact with hormone-primed opposite-sex partner when given a choice of 
gonadectomized animal with hormone treatment versus without treatment. This finding 
was unexpected since, based on previous literature (Pankevich et al., 2004), we expected 
both males and female to show this preference. However, when examined in evolutionary 
context, this result supports previous findings that females are the “choosier” sex and 
have higher investment in offspring rearing, thus their preference for the hormone-primed 
animal might be necessitated by the need to select a more advantageous potential mate 
(Crews et al., 2007). We also found that males took longer time to begin investigating the 
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stimulus animal and spent more time standing still and grooming. These data similarly 
suggest that males are less interested in sociosexual interactions. Males treated prenatally 
with EB, 0.5mg/kg A1221 or 1mg/kg A1221 spent less time nose-touching with stimulus 
animals, irrespective of the hormone status of the stimulus animal. The same animals 
have been previously analyzed in a sociability experiment where males treated with 
prenatal 0.5mg/kg A1221 exhibited an overall decrease in nose-to-nose investigations 
(Reilly et al., under review). The differences between Reilly study and this report might 
stem from the different social context where nose-touch was examined: sociosexual vs. 
sociability. Nevertheless, nose-touching in males is sensitive to endocrine disruption by 
PCBs, and in a sociosexual context, PCB might be exerting their effect via estrogenic 
mechanisms.   
 
Steroid hormone receptors and Kiss1 gene expression was increased in 0.5mg/kg 
A1221 in the MPN of females 
In the MPN, 0.5mg/kg A1221 treatment increased the gene expression of Ar, 
Esr1, Esr2 and Kiss1 in females, but not males. This finding was unexpected since 
previously our lab has reported decreased Ar expression in preoptic area in adult 1mg/kg 
A1221 females (Dickerson et al., 2011b). However, the differences in gene expression 
results might stem from using a lower 0.5mg/kg A1221 dose. A1221 is known to be 
estrogenic (Dickeron et al., 2007), but at lower doses it has also shown anti-estrogenic 
activity (Kelce et al., 1997; Schantz et al., 2001). Thus, it is possible that Ar, Esr1, Esr2 
and Kiss1 gene upregulation in the MPN is due to the anti-estrogenic effects of A1221.  
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Neuroendocrine genes in the VMN are affected by PCBs in a sex and treatment-
specific manner 
In the VMN, the effects of PCB treatment were sex- and treatment-specific. In 
females, EB increased Esr1 gene expression, while 0.5 mg/kg A1221 decreased 
expression of Drd1a, and 1 mg/kg A1221 increased expression of Avpr1a. These genes 
are involved in neuroendocrine function and have established gene-behavior relationships 
in social and sociosexual behaviors (De Vries et al., 1984; Bale et al., 1995; Ferguson et 
al., 2001; Nomura et al., 2002). We suggest that changes to these genes may underlie the 
increase in ultrasonic vocalizations observed in 0.5mg/kg A1221 females. In males, the 
main effect of prenatal EB and 0.5 mg/kg A1221 increased expression of Crh, 0.5 mg/kg 
A1221 increased the expression of Foxp2 and Lepr, and 1 mg/kg A1221 increased the 
expression of Oxt. Some of these gene products regulate social behavior (e.g. Oxt, Crh, 
Foxp2) as well as feeding behaviors (Lepr). We suggest that changes in the pattern of 
expression of these genes may underlie changes to sociosexual interactions in males 
(decreased nose-touching in EB, 1mg/kg A1221 and 0.5mg/kg A1221 males).  
 
0.5mg/kg A1221 group had the highest number of USV-associated correlations in 
the bionetwork analysis 
The networks were examined for organization (total number of correlations) and 
the identity of relationships. The most complex network organization in both MPN and 
VMN was exhibited in the 0.5mg/kg A1221 animals. When examined for USV-
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associated measures, 0.5mg/kg A1221 networks exhibited a higher number of measures 
that correlated with bandwidth of rise calls. This finding supports the higher number of 
USVs in the 0.5mg/kg A1221 males and females. In general, bionetwork findings 
correlated with the finding that 0.5mg/kg A1221 group had the highest number of 
behavioral and molecular changes of all treatment groups, compared to DMSO.  
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Chapter 4: General discussion 
 
In 1962, Rachel Carson in her book “Silent Spring” documented the detrimental 
effects on the environment – particularly on birds – from the indiscriminate use of 
pesticides (Carson, 1962). Her book brought environmental concerns to the American 
public, and inspired an environmental movement that led to the creation of U.S. 
Environmental Protection Agency. More than 50 years later, endocrinologists have 
advanced the knowledge on the understanding of how pesticides and other exogenous 
environmental chemicals influence wildlife and humans. Recent scientific evidence has 
linked a class of these compounds, known as endocrine-disrupting chemicals (EDCs) to 
an overall decline in human reproductive health (Chandra et al., 2005). The structures of 
these compounds enable them to mimic steroid hormones and interact with endocrine 
systems throughout development and into adulthood. There are documented effects of 
EDCs on the reproductive, growth, thyroid, stress, and lactotrophic endocrine systems 
(Dickerson et al., 2007; Zoeller, 2005; Anderson, 2010; Schantz et al., 2001; Scarth 
2006). Such effects are particularly detrimental during the critical period of development, 
when the reproductive organs, genitalia, and the brain are sculpted into sexually 
dimorphic structures with the help of endogenous hormones. This chapter will review the 
findings of this dissertation and provide a detailed discussion and implications of the 
findings.  
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Gestational PCBs and microRNA expression  
In Chapter 2, the expression of eight microRNAs and select relevant target genes 
were analyzed for effects of sex, age, and gestational PCB treatment during postnatal 
development at postnatal [P] day 15, P30, P45, and P90 in male and female rats. The 
relationship between microRNA and mRNA gene expression was examined in the 
bionetwork analysis. 
In the MPN, the most important finding was a developmental increase in 
microRNA expression with age, during the transition from juvenile (postnatal [P] day 15) 
to pubertal period (P30). Six microRNAs (mir-132, mir-219, mir-7, mir-145, let-7a, and 
let-7b) showed this increase with age in the MPN. The previous literature has linked the 
expression of four of the microRNAs (let-7a, let-7b, mir-132, and mir-145) to 
mechanisms leading to or permitting the onset of puberty in rats (Sangiao-Alvarellos et al 
2012). The expression pattern of let-7a, let-7b, mir-132, and mir-145 had been previously 
examined in the preoptic area in the hypothalamus of the developing rats, and as in this 
work, was found to increase with age (Sangiao-Alvarellos et al., 2012). Numerous age-
related changes in microRNA expression have also been observed in the female aging rat 
brain (Rao et al., 2013). This suggests that the developmental effects of age on 
microRNA expression are important during the transitional hormone-sensitive periods in 
development, such as puberty.  
Puberty is characterized by significant increase in serum hormone levels, which 
exert effects on reproductive and non-reproductive tissues to prepare the individual for 
sexual maturity (Matochik et al., 1994). During puberty, which occurs around P30-P45 in 
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rats, hormone-sensitive changes at all levels of the HPG axis have been reported, 
including but not limited to changes in gene and protein expression. MicroRNAs regulate 
target gene expression by inducing mRNA proteolytic degradation, and/or inhibition of 
protein translation (Kim et al., 2009). This dissertation evaluated the effects of 
microRNA perturbation by examining target gene mRNA expression in the same-aged 
animals, and, surprisingly, did not find the predicted inverse relationship with microRNA 
expression. However, this does not necessarily dictate that microRNAs had no effect on 
protein expression. As microRNAs exert their influence through reduced translational 
activity, in addition to mRNA degradation, it is possible that protein expression was 
reduced with no corresponding decrease in mRNA. Further studies correlating 
microRNA levels with protein expression should be conducted.  
In the MPN, another major finding was the discovery that microRNAs are 
sexually dimorphic, with the sexual dimorphisms most apparent during puberty. Females 
had higher levels of expression of mir-219, mir-7, and mir-145 than males, an effect 
driven by differences at P30. Males, on the other hand, had higher levels of expression of 
mir-9 and let-7b at P45. Thus, these differences are possibly involved in the pubertal 
changes in the MPN, and may be the result of hormone-related changes during puberty as 
the hypothalamus transitions from juvenile quiescence to adult function.  
The results of EDC treatment on microRNA expression in the MPN were age and 
sex specific. In females, prenatal A1221 and EB increased expression of mir-219, mir-
132, mir-7, mir-145, let-7a, and mir-124a at P30. It is worth noting that similarities 
between A1221 and EB are consistent with their similar actions on estrogenic pathways. 
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In the male MPN, expression of all 8 miRNAs examined was decreased in prenatally 
treated A1221 males on P90, an effect not mimicked by EB. In addition to being 
estrogenic, A1221 is known to be partially anti-estrogenic and anti-androgenic (reviewed 
in Schantz et al., 2001), thus it is possible that A1221 effects on the male MPN were 
mediated via its partial antagonistic actions at the estrogen receptor or, perhaps more 
likely, agonistic actions at the androgen receptor.  
In the VMN, expression of all eight examined microRNAs increased with age, 
with the difference driven by the increase in expression from juvenile [P15] to pubertal 
[P30] levels. This finding was expected as mir-132, mir-7, mir-145, let-7a, and let-7b 
were previously found to increase with age in medial basal hypothalamus (Sangiao-
Alvarellos et al., 2013). Similar to the MPN, the microRNA expression profiles in the 
VMN suggest that microRNA levels vary the most during the transition from juvenile to 
adult. Interestingly, in the VMN, mir-9 expression increased with age, despite previous 
reports on its age-related decrease in medial basal hypothalamus, which contains the 
VMN (Sangiao-Alvarellos et al., 2013). The finding of age-related increase in mir-9 
expression in the more precise VMN underscores the tissue specificity of microRNA 
expression.  
There were no effects of sex and relatively few effects of EDC treatment on 
microRNA expression in the VMN. In the females, there were age-specific EDC effects 
in let-7a, mir-124a, and mir-219 expression; while in the male VMN, A1221 decreased 
the expression of mir-124a. Additionally, since only a handful of microRNAs were 
examined, it is possible that other microRNAs would have shown more EDC-related 
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effects in the VMN. It was surprising to observe no sex-related changes in the microRNA 
expression in the VMN, given the rich literature of sexually dimorphic gene and protein 
expression in the region (Herbison et al., 1995; Cao et al., 2011).  
To ascertain the functional importance of microRNA changes, the expression of 
several target mRNAs (Ar, Clock, Lepr, Lin28b, Ppara, Grin2a, Igf1r, Ar, Pgr) was 
analyzed in the same animals. Within sex, modest effects of age and EDC effects were 
observed in both regions. Contrary to predictions, the data did not show an inverse 
relationship between microRNA and mRNA expression. In fact, in the bionetwork 
analysis, only positive relationships between microRNAs, mRNAs, and estradiol and 
testosterone serum hormone levels were observed. Such finding could be due to a number 
of possibilities. First, out of 2000 microRNAs currently catalogued in mammals (Olive et 
al., 2015), only eight microRNAs were examined. It is possible that other microRNAs 
not measured have stronger associations with the examined mRNAs. Second, the effects 
of the selected microRNAs might not be as strong as anticipated, and thus their effects 
were masked by additional gene regulatory mechanisms such as DNA methylation, 
histone modifications, transcriptional factors, and other various forms of regulation. 
Third, protein expression was not analyzed, thus it is possible that reported microRNA 
changes contributed to inhibition of protein translation.  
This study documented postnatal microRNA expression profiles in two 
hypothalamic nuclei, MPN and VMN for the effects of age, sex, and EDC treatment. I 
found that individual microRNAs were affected in both a sexually dimorphic and age-
specific manner in prenatally PCB-exposed individuals. Importantly, these results 
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underlie the importance of age of analysis in examination of gestational PCB effects on 
adult endpoints. This is not surprising, as the profiles of different genes and proteins in 
the brain undergo dynamic change throughout postnatal development (Kermath et al., 
2014). This study and others (Sangiao-Alvarellos et al., 2013; Rao et al., 2014) also 
suggest the importance of hormone-sensitive periods in development, such as puberty and 
menopause. Additionally, these studies point to the possibility that microRNAs are 
gestationally programmed by estradiol and altered by estrogenic PCBs during embryonic 
development.  Thus, studies to elucidate the timing of organizational events in microRNA 
programming in utero should be undertaken to better understand their importance in 
neural development.  
 
Gestational PCBs, adult behaviors, and mRNA expression 
In Chapter 3, I examined the sex and gestational effects of 50ug/kg EB (positive 
control), 1mg/kg A1221, or 0.5mg/kg A1221 treatment on two sociosexual behaviors, 
ultrasonic vocalizations and partner preference. For these behaviors, number and quality 
of ultrasonic vocalizations produced after an encounter with an opposite-sex partner were 
analyzed, as was time spent with a hormone-implanted opposite-sex rat or a hormone-
deprived opposite-sex animal. Finally, gene expression of 48 candidate neuroendocrine 
genes was measured in the MPN and VMN of the behaviorally characterized rats. The 
endpoints were selected to provide a broad assessment of how gestational PCBs alter 
developing neuroendocrine systems, sex-typical reproductive function, and behaviors in 
adulthood. This work provides novel insight into the mechanisms through which 
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gestational low-level exposures to PCBs disrupt neuroendocrine function in adult 
animals. 
Ultrasonic vocalizations were found to be sexually dimorphic and influenced by 
the animal’s sociosexual environment. The number of flat, rise, step USVs, but not trill 
USVs was sexually dimorphic, with females vocalizing more USVs than males. I also 
found that both males and females vocalized higher number of USVs after interaction 
with an opposite-sex animal. Bandwidth and entropy of the USVs were examined and 
found to be sexually dimorphic, with female calls having higher bandwidth and entropy 
than male calls. This implies that females have a greater interest in producing 
vocalizations, or have a greater capacity at vocalizing at higher numbers. Additionally, 
increases in USVs following exposure to an opposite-sex animal suggest that sociosexual 
cues are a significant factor for USV production in both sexes.   
PCB exposure significantly affected USV production. Prenatal treatment with 
0.5mg/kg A1221 increased the number of rise calls in both males and females, and 
number of step calls in males. Following interaction with an opposite-sex partner, an 
increase in vocalizations was observed only for numbers of rises, steps and trills in 0.5 
mg/kg A1221-treated females and numbers of rises and steps in the 0.5 mg/kg A1221-
treated males. In the same animals, the effects of gestational EDCs on bandwidth and 
entropy were examined. Prenatal EB and 1mg/kg A1221 treatment increased bandwidth 
of male rise and trill calls, respectively. This finding suggests that USV production is a 
sensitive measure of endocrine disruption, and sex differences in USVs may be altered 
during gestation by PCBs. The PCB effect on USV numbers was not mimicked by the EB 
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treatment, thus it is unlikely PCBs are acting via estrogenic mechanisms. A1221 is 
known to be anti-estrogenic and androgenic, thus it is possible A1221 effects on USVs 
occurred via its antagonistic actions at the estrogen receptor, or agonistic action at the 
androgen receptor. Importantly, gestational PCB exposure in the males resulted in 
female-like numbers, entropy, and bandwidth of vocalizations. Analysis via a principle 
component analysis, identified five USV measures that were highly sensitive indicators 
of sex differences in the examined animals; bandwidth of trill and step USVs, duration of 
rise and step USVs, and numbers of flat USVs. However, PCB treatment did not produce 
an overall feminizing effect. The doses of PCBs used in the study are in the very low-
level range of exposures, similar to the levels of PCB exposure found in the environment, 
however the exposure occurred only during gestation, while humans may be exposed to 
PCBs continually throughout development, and in adulthood. Thus, effects of multiple 
low-level exposures on vocalizations warrants further investigation. These findings also 
highlight the extent of the detriment that can be caused by even the lowest levels of 
exposure to PCBs during pregnancy.  
The sociosexual preference behaviors, namely whether the rats preferred to spend 
time with the gonadectomized, hormone-primed versus gonadectomized hormone-
deprived opposite-sex animals, were also examined. Males, but not females, lacked the 
preference for the hormone-primed partner, and are more sensitive to PCB disruption. For 
example, females, but not males, spent more time near the hormone primed stimulus 
animal, investigating its enclosure, and nose-touching with it compared to the castrated 
animal. This result supports previous findings that females are the “choosier” partners, 
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due to their higher investment in offspring rearing, thus their preference for the hormone-
primed animal might be necessitated by the need to select a more advantageous potential 
mate. In addition, males were slower to start investigating the stimulus animal enclosure 
and spent more time standing still and grooming. Thus, these data similarly suggest that 
males are less interested in sociosexual interactions. 
This dissertation also examined a multitude of sociosexual behaviors, and found 
that nose-touching was the only measure of dyadic interaction that was altered in PCB-
treated animals. Gestational exposure to EB, 0.5mg/kg A1221 or 1mg/kg A1221 resulted 
in decreased nose-touching in treated males. The effects of PCB treatment were 
mimicked by EB, and thus may be potentiated via estrogenic mechanisms. This also 
suggests that nose-touching is a sensitive measure of endocrine disruption. In a similar 
study by Reilly et al, nose-touching behavior was similarly decreased in PCB-treated 
males in a social recognition experiment (Reilly et al., under review). Thus, nose-
touching is a sensitive indicator of PCB exposure and in future studies, nose-touching 
alone may be used to evaluate disruption of sociosexual and social behaviors.  
Expression of 48 neuroendocrine genes was examined in the MPN and VMN of 
the behaviorally characterized animals. In the MPN, steroid hormone receptor (Ar, Esr1, 
Esr2) and Kiss1 gene expression was increased in 0.5mg/kg A1221 females, while the 
males were unaffected. Since the effects of PCBs were not mimicked by EB, it is likely 
that the effect was not mediated via PCB effects on estrogen receptor. Effects of PCB 
treatment in the VMN were sex- and treatment-specific. In females, EB increased Esr1 
gene expression, 0.5 mg/kg A1221 decreased expression of Drd1a, and 1 mg/kg A1221 
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increased expression of Avpr1a. In males, EB and 0.5 mg/kg A1221 increased expression 
of Crh, 0.5 mg/kg A1221 increased the expression of Foxp2 and Lepr, and 1 mg/kg 
A1221 increased the expression of Oxt. It is interesting to note that PCBs affected 
expression in the MPN and VMN differently. Gene expression, behaviors, and serum 
corticosterone were examined in the bionetwork analysis. In general, 0.5mg/kg A1221 
networks were the most distinct, and different from vehicle. This correlates with the 
finding that 0.5mg/kg A1221 group had the highest number of behavioral and molecular 
changes of all treatment groups, compared to vehicle.  
 
Concluding remarks 
Taken together, the results of this dissertation provide novel insight into the 
effects of gestational PCBs on adult reproductive physiology and behavior. The 
dissertation contains novel findings on PCB effects on first, hypothalamic microRNA and 
related target mRNA expression during postnatal development, and second, adult 
reproductive behaviors and candidate neuroendocrine hypothalamic gene expression. In 
Chapter 2, PCB effects on microRNA expression were region-, sex- and age-specific, 
with most changes observed in the MPN. In the females, prenatal PCB treatment 
increased microRNA expression during puberty [P30], and in the males, PCB effects on 
microRNA expression were observed in adulthood [P90]. In Chapter 3, prenatal PCB 
treatment increased the number of ultrasonic vocalizations and altered the acoustic 
qualities of the calls in treated females and males. In the PCB-treated females, but not the 
males, the gene expression of estrogen receptor alpha, estrogen receptor beta, androgen 
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receptor, and kisspeptin genes was increased in the MPN. The results of this dissertation 
research have relevance for human public health and disease, as EDCs are increasingly 
linked to reproductive decline in humans (Chandra et al., 2005). Indeed, a growing body 
of scientific evidence suggests that early life exposure to EDCs may alter development of 
reproductive tract and genitalia and hormonal responsiveness in adulthood (reviewed in 
Diamanti-Kandarakis et al., 2009). Coupled with this evidence are a number of disturbing 
trends in some geographic regions, including reduction in fertility, an increase in 
hormone sensitive cancers, an earlier age of puberty in girls, and a decrease in the 
number of boys being born (reviewed in Janssen et al., 2007). Additional basic and 
translations studies that investigate the EDC effects during gestation are needed to 
uncover the mechanisms behind these disease phenotypes. 
 
Future directions 
This dissertation is a precursor to an understanding of the complex regulatory 
mechanisms underlying effects of endocrine disruption and could be expanded in several 
ways. For example, using the microRNA candidates that were identified in the 
dissertation, microRNA mimic and antagomir studies could be conducted using cells 
expressing target mRNAs (e.g. hypothalamic GT1 cells) to measure gain and loss of 
microRNA function and demonstrate the specificity of target mRNA and protein 
downregulation by select microRNAs. Additionally, select microRNA antagomir/mimics 
could be infused directly into specific nuclei in the brains of prenatally-exposed adult or 
adolescent rats to ameliorate or reverse the effects of endocrine disruption. Finally, the 
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dissertation could be expanded by altering the timing of exposure to PCBs allowing us to 
identify and define a window of susceptibility for PCB exposure, thereby shedding light 
on the organizational vs. activational effects of PCBs and their long-term consequences 
on health outcomes. 
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